{"gene":"MMP1","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":1986,"finding":"MMP1 (human fibroblast collagenase) is synthesized as a preproenzyme (Mr 54,092) with a 19-amino-acid signal peptide; proteolytic activation removes 81 amino-terminal residues, yielding the active enzyme; the sequence is homologous to an oncogene-induced rat protein.","method":"cDNA cloning and sequence analysis of human skin collagenase mRNA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — primary sequence determination by cDNA cloning, foundational paper with 663 citations","pmids":["3009463"],"is_preprint":false},{"year":1986,"finding":"The MMP1 (collagenase) gene contains a 32-bp 5'-flanking element (positions −73 to −42) that functions as a phorbol-ester (TPA)-inducible enhancer, acting in a position- and orientation-independent manner to drive transcription.","method":"5' and 3' deletion mutagenesis of the MMP1 promoter region followed by transfection into human/murine cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — direct mutagenesis with functional readout; foundational paper with 745 citations","pmids":["3037355"],"is_preprint":false},{"year":1994,"finding":"The crystal structure of the MMP1 catalytic domain complexed with an inhibitor at 2.4 Å resolution revealed a catalytic zinc ion, a second structural zinc ion, and a calcium ion critical for tertiary structure stability; the fold is homologous to thermolysin and astacin despite low sequence homology.","method":"X-ray crystallography of inhibitor-bound MMP1 catalytic domain","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional inhibitor complex; 278 citations","pmids":["8278810"],"is_preprint":false},{"year":1994,"finding":"MMP1 (along with MMP-3) degrades insulin-like growth factor-binding protein-3 (IGFBP-3) in vitro, cleaving within the mid-region of the binding protein, suggesting a role for MMP1 in modulating IGF bioavailability.","method":"Immunoaffinity depletion of MMPs from conditioned medium, in vitro cleavage assays with purified recombinant enzymes, and N-terminal sequencing of cleavage products","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro cleavage with sequencing of cleavage sites; 269 citations","pmids":["7523391"],"is_preprint":false},{"year":1994,"finding":"Human skin mast cell chymase directly activates interstitial procollagenase (pro-MMP1) by cleaving the Leu83–Thr84 bond in a single step, without intermediate species; heparin accelerates this activation and prevents further degradation of active MMP1.","method":"In vitro activation assays with purified human chymase and procollagenase, N-terminal sequencing of activation products, time- and concentration-dependence measurements","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted biochemical activation with precise cleavage-site sequencing; 260 citations","pmids":["8027075"],"is_preprint":false},{"year":1995,"finding":"MMP-7 (matrilysin) activates pro-MMP1 by cleaving the Gln80–Phe81 bond, an activity enhanced ~6.5-fold in the presence of APMA, revealing a cascade activation mechanism among MMPs.","method":"In vitro activation assays with purified MMP-7 and pro-MMP1, N-terminal sequencing","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted biochemical assay with cleavage-site identification; 257 citations","pmids":["7896811"],"is_preprint":false},{"year":1999,"finding":"MMP1 is a zinc-dependent endopeptidase and the most ubiquitously expressed interstitial collagenase; it is the primary enzyme responsible for initial cleavage of fibrillar collagens (especially types I, II, III) within the extracellular matrix. Its activity is controlled transcriptionally, by zymogen activation, and by TIMPs.","method":"Comprehensive review/biochemical characterization collating structural, enzymatic, and inhibitor data","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — foundational review synthesizing extensive biochemical data; 3561 citations","pmids":["10419448"],"is_preprint":false},{"year":2000,"finding":"MMP1, MMP-13, and other collagenases (but not MMP-7, MMP-8, or MMP-9) cleave monocyte chemoattractant protein-3 (MCP-3) between residues 4 and 5, generating antagonists of CC chemokine receptors CCR-1, -2, and -3 that inhibit chemotaxis and reduce inflammation in vivo.","method":"In vitro cleavage of recombinant chemokines by 8 recombinant MMPs, receptor-binding assays, transwell migration assays, in vivo carrageenan paw-edema model","journal":"Science / Blood","confidence":"High","confidence_rationale":"Tier 1 — reconstituted cleavage assay with multiple MMPs, in vitro receptor assays, and in vivo validation; replicated across two papers","pmids":["10947989","12149192"],"is_preprint":false},{"year":2001,"finding":"The region of MMP1 encoded by exon 5 determines substrate specificity (collagenolytic activity) and inhibitor selectivity: a chimeric enzyme with MMP-3's exon-5 region substituted for MMP-1's retained only ~2.2% of wild-type collagenolytic activity against type I collagen and displayed MMP-3-like kinetics on synthetic substrates and with TIMP-2.","method":"Chimeric enzyme construction (exon-5 swap between MMP-1 and MMP-3), in vitro collagen cleavage assays, synthetic substrate kinetics, TIMP inhibition assays","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis/chimera with multiple in vitro functional readouts","pmids":["11248710"],"is_preprint":false},{"year":2005,"finding":"MMP-1 functions as a protease agonist of PAR1 (protease-activated receptor-1): MMP-1 derived from stromal fibroblasts cleaves PAR1 at the correct site to generate PAR1-dependent Ca2+ signals and promotes breast carcinoma cell migration and invasion in a xenograft model.","method":"Xenograft tumor model, PAR1 expression/knockdown, Ca2+ signaling assays, migration assays, MMP-1 activity assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — receptor cleavage confirmed with signaling readout and in vivo xenograft; 664 citations","pmids":["15707890"],"is_preprint":false},{"year":2006,"finding":"In Drosophila, JNK signaling resulting from loss of the polarity gene scribble promotes tumor cell invasiveness through Fos-dependent transcriptional activation of mmp1 downstream of JNK; TIMP expression or Mmp1 RNAi knockdown suppresses invasion, placing Mmp1 as the effector of JNK-driven invasion in a Ras-cooperative tumor context.","method":"Genetic epistasis in Drosophila imaginal disc clones: RNAi knockdown of mmp1, TIMP overexpression, loss-of-function/gain-of-function of JNK/Ras pathway components, invasion assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — clean genetic epistasis with multiple loss-of-function approaches and defined invasion phenotype; 332 citations","pmids":["17082773"],"is_preprint":false},{"year":2007,"finding":"MMP1 and MMP-2 together facilitate the release of circulating tumor cells into the bloodstream and their extravasation into the lung to seed pulmonary metastasis; MMP1 (expressed in human breast cancer cells) is required for tumor blood-vessel assembly and breaching of lung capillaries.","method":"Genetic knockdown and pharmacological inhibition of MMP1/MMP2 in breast cancer xenograft and lung metastasis models; angiogenesis assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genetic/pharmacological loss-of-function with specific in vivo metastatic phenotype; 554 citations","pmids":["17429393"],"is_preprint":false},{"year":2008,"finding":"UV-induced DNA damage in epidermal keratinocytes is a primary trigger for MMP-1 induction in both the epidermis and dermis: photolyase-mediated repair of UV-induced DNA lesions in keratinocytes reduced MMP-1 mRNA and protein in skin, and conditioned medium from UV-irradiated keratinocytes induced MMP-1 in unirradiated fibroblasts through soluble mediators; DNA-repair enzyme pretreatment of keratinocytes blocked this paracrine MMP-1 induction.","method":"Liposome-encapsulated DNA repair enzymes applied to human skin ex vivo; conditioned medium transfer experiments between irradiated keratinocytes and unirradiated fibroblasts; MMP-1 mRNA/protein measurement","journal":"Experimental dermatology","confidence":"High","confidence_rationale":"Tier 2 — mechanistic dissection using DNA repair enzymes and conditioned medium transfer with defined molecular readouts","pmids":["18459971"],"is_preprint":false},{"year":2008,"finding":"Met receptor tyrosine kinase phosphorylates MUC1 cytoplasmic tail at the YHPM tyrosine; phosphorylated MUC1CT translocates to the nucleus, enhances its interaction with p53, which suppresses AP-1 transcription factor activity at the MMP1 promoter, thereby reducing MMP1 transcription and HGF-induced cancer cell invasiveness.","method":"Co-IP, real-time confocal imaging of nuclear MUC1CT localization, kinase assays, AP-1 reporter assays, promoter-interaction studies, invasion assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — phosphorylation site identified, nuclear localization directly imaged, promoter occupancy linked to MMP1 expression and invasion","pmids":["18625714"],"is_preprint":false},{"year":2008,"finding":"Akt blockade in human dermal fibroblasts upregulates MMP1 production and reverses TGF-β-mediated MMP1 suppression, while simultaneously reducing type I collagen; this dual profibrotic role of Akt (increasing collagen and decreasing MMP1-mediated degradation) is exacerbated in systemic sclerosis fibroblasts.","method":"Pharmacological Akt inhibitors, siRNA knockdown, dominant-negative Akt mutant; Western blot for collagen and MMP1; SSc fibroblast comparison","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 — multiple independent inhibition strategies (pharmacological + siRNA + dominant-negative) with consistent MMP1 phenotype","pmids":["18323784"],"is_preprint":false},{"year":2009,"finding":"ADAMTS1 and MMP1, expressed by tumor cells, orchestrate a paracrine signaling cascade in bone metastasis: both metalloproteinases proteolytically release membrane-bound EGF-like ligands (AREG, HB-EGF, TGFα) from tumor cells, which then suppress osteoprotegerin (OPG) in osteoblasts via EGFR, thereby potentiating osteoclast differentiation and osteolytic bone metastasis.","method":"In vitro and in vivo bone metastasis models, siRNA knockdown of MMP1/ADAMTS1, EGFR inhibitors, EGF-like ligand release assays, osteoclast differentiation assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — genetic and pharmacological loss-of-function with mechanistic dissection of substrate release and downstream signaling; 247 citations","pmids":["19608765"],"is_preprint":false},{"year":2005,"finding":"Cdc42 downregulates MMP-1 expression in human skin fibroblasts by suppressing the ERK1/2 pathway: Cdc42 siRNA silencing caused a 15-fold increase in MMP-1 secretion that was dependent on ERK1/2 (but not p38 or RhoA-ROCK), and was partially reduced by co-silencing Rac1, placing Cdc42 upstream of Rac1 and ERK1/2 in the regulation of MMP-1.","method":"siRNA silencing of Cdc42, RhoA, and Rac1; rescue with wild-type Cdc42; chemical kinase inhibitors; ERK1/2 and p38 phosphorylation assays; MMP-1 mRNA and secretion measurement","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — multiple siRNAs + siRNA rescue + chemical inhibitors establishing epistatic pathway; 57 citations","pmids":["15728253"],"is_preprint":false},{"year":2005,"finding":"EPA inhibits UV-induced MMP-1 expression in human dermal fibroblasts by blocking activation of MEK1/ERK and SEK1/JNK kinases, thereby reducing c-Fos expression and c-Jun phosphorylation and suppressing AP-1 DNA binding activity; this effect is independent of antioxidant activity.","method":"In vitro UV irradiation of fibroblasts with EPA pretreatment; kinase inhibitors; AP-1 EMSA; c-Fos/c-Jun Western blots; MMP-1 mRNA/protein measurement","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 — pathway dissection using multiple pharmacological inhibitors combined with transcription factor binding assays","pmids":["15930517"],"is_preprint":false},{"year":2007,"finding":"IL-17 induces MMP-1 expression in primary human cardiac fibroblasts through p38 MAPK- and ERK1/2-dependent activation of AP-1 (c-Fos, c-Jun, Fra-1), NF-κB (p50/p65), and C/EBP-β; inhibiting any of these transcription factors attenuates MMP-1 expression.","method":"siRNA knockdown, antisense oligonucleotides, dominant-negative expression vectors, pharmacological kinase inhibitors (SB-203580, PD-98059), EMSA, reporter assays, Northern blot, ELISA","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal loss-of-function approaches delineating AP-1/NF-κB/C-EBP pathway upstream of MMP-1; 214 citations","pmids":["17921324"],"is_preprint":false},{"year":2010,"finding":"Akt inhibition upregulates MMP1 in human dermal fibroblasts through a CCN2 (CTGF)-dependent pathway: Akt blockade induces CCN2 expression, which in turn activates ERK1/2 and Ets1 phosphorylation, leading to MMP1 transcription; ERK1/2 inhibition abolishes CCN2-driven MMP1 induction.","method":"Pharmacological Akt inhibitor, Akt siRNA, CCN2 siRNA, ERK1/2 inhibitor (UO126), Western blotting for phospho-ERK1/2 and phospho-Ets1, MMP1 protein/mRNA measurement","journal":"Experimental dermatology","confidence":"High","confidence_rationale":"Tier 2 — two independent Akt inhibition methods combined with CCN2 siRNA rescue and kinase pathway dissection","pmids":["20201953"],"is_preprint":false},{"year":2011,"finding":"MMP1 promoter polymorphism (identified by ChIP) creates binding sites for transcription factors ETS1, ETS2, and GATA3; the allelic variant that accommodates these transcription factor binding events drives bimodal MMP1 mRNA expression across individuals in endothelial cells both at baseline and in response to inflammatory mediators.","method":"Hierarchical clustering of microarray data from 15 HUVEC individuals, RT-PCR validation, MMP1 activity assays, DNA sequencing of 69 individuals, chromatin immunoprecipitation (ChIP) for ETS1/ETS2/GATA3","journal":"BMC genomics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP identifies transcription factor binding, but single-lab study with population-level functional inference","pmids":["21244711"],"is_preprint":false},{"year":2013,"finding":"Cdc42 negatively regulates MMP-1 expression in collagen-activated human keratinocytes by suppressing ERK activity; contact with type I collagen via α2β1 integrin activates ERK (but not JNK or p38), and ERK inhibition blocks collagen-stimulated MMP-1 expression and keratinocyte migration on collagen.","method":"ERK, p38, and JNK pharmacological inhibitors; Cdc42 activity analysis; MMP-1 mRNA/protein in primary neonatal and adult keratinocytes stimulated with type I collagen","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 — integrin→ERK→MMP-1→migration axis established with orthogonal inhibitors in primary cells","pmids":["24352036"],"is_preprint":false},{"year":2014,"finding":"Fluid shear stress above a threshold (~10 dyn/cm²) triggers endothelial cell sprouting (angiogenesis) through upregulation of MMP1; siRNA-mediated MMP1 knockdown abrogates flow-induced sprouting, establishing MMP1 as a required downstream effector of shear-stress-driven angiogenesis.","method":"Microfluidic shear stress devices, siRNA knockdown of MMP1, sprouting/invasion assays in 3D matrix","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — siRNA loss-of-function with defined cellular phenotype in well-controlled microfluidic system; 302 citations","pmids":["24843171"],"is_preprint":false},{"year":2015,"finding":"In Drosophila metamorphosis, Mmp1 preferentially cleaves DE-cadherin-mediated cell–cell junctions (while Mmp2 degrades basement membrane), and cooperative action of both MMPs is required for complete fat body tissue dissociation into individual cells.","method":"Fat body-specific RNAi screen in Drosophila, biochemical substrate assays, genetic interaction experiments, cellular imaging","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — RNAi screen plus genetic epistasis and substrate characterization; distinct roles of Mmp1 vs Mmp2 established","pmids":["25520167"],"is_preprint":false},{"year":2015,"finding":"miR-203 overexpression in rheumatoid arthritis synovial fibroblasts leads to increased secretion of MMP-1 and IL-6 via the NF-κB pathway; DNA demethylation (5-azaC) increases miR-203 expression, identifying methylation-dependent epigenetic regulation as a mechanism controlling MMP-1 levels in RA fibroblasts.","method":"miR-203 precursor transfection in RASFs, NF-κB pathway inhibition (SC-514), real-time PCR, ELISA for MMP-1 and IL-6, 5-azaC treatment","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function miRNA with pathway inhibitor confirming NF-κB link; 262 citations","pmids":["21279994"],"is_preprint":false},{"year":2015,"finding":"miR-526b directly targets the 377–383 region of the MMP1 3' UTR to suppress MMP1 mRNA expression; reporter constructs with mutated 3'UTR abolished this regulation, and miR-526b and MMP1 mRNA show inverse expression between adult dermal and neonatal fibroblasts.","method":"3'UTR luciferase reporter assays with wild-type and mutant MMP1 3'UTR, miR-526b overexpression, RT-PCR in dermal/neonatal fibroblasts","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — direct 3'UTR targeting confirmed by mutagenesis of binding site, single lab","pmids":["26292968"],"is_preprint":false},{"year":2016,"finding":"MMP1 secreted by transformed (H-Ras-oncogenic) epithelial cells cleaves laminin subunit alpha-5 (LAMA5), generating proteolytic fragments that promote endothelial cell angiogenesis via integrin αvβ3; MMP1 knockdown reduces tumor invasion, anchorage-independent growth, and xenograft tumor volume, and diminishes the angiogenic potency of the secretome.","method":"MMP1 siRNA knockdown in 21D1 cells, in vivo xenograft, secretome transfer to fibroblasts/endothelial cells, angiogenesis assays, integrin αvβ3 antibody inhibition, mass spectrometry identification of LAMA5 as MMP1 substrate","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1-2 — novel substrate identified by mass spectrometry, functional validation in vitro and in vivo, integrin pathway confirmed","pmids":["27324842"],"is_preprint":false},{"year":2016,"finding":"The DDR2–AP-1–CYR61–ETS1–MMP1 signaling loop in fibroblast-like synoviocytes (FLS) mediates collagen II-induced bone erosion in rheumatoid arthritis: collagen II activates DDR2 phosphorylation → AP-1 → CYR61 expression → ETS1-driven MMP1 production → FLS invasion and migration; adenoviral CYR61 shRNA in vivo reduces arthritis severity and bone erosion.","method":"siRNA/shRNA knockdown, adenoviral shRNA in vivo (CIA rat model), micro-CT, AP-1 ChIP, co-IP, FLS invasion/migration assays","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 2 — multi-step pathway validated by independent knockdowns and in vivo shRNA model with bone erosion readout","pmids":["27653023"],"is_preprint":false},{"year":2017,"finding":"Slug (SNAI2) directly binds three E-box/Slug-binding sites in the MMP1 promoter to enhance MMP1 transcription in breast cancer cells with multi-drug resistance; ChIP-qPCR and dual luciferase assays confirmed direct promoter binding, and MMP1 overexpression reduced drug sensitivity while MMP1 knockdown enhanced sensitivity in MDR cells.","method":"Dual luciferase assays with MMP1 promoter constructs, ChIP-qPCR, Slug overexpression/knockdown, MMP1 overexpression/knockdown, drug sensitivity assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — direct promoter binding confirmed by ChIP and mutagenesis; functional consequence in drug resistance established","pmids":["28334049"],"is_preprint":false},{"year":2018,"finding":"The transcriptional repressor Capicua (CIC) suppresses HCC progression by repressing ETV4 expression; ETV4 in turn directly drives MMP1 expression in HCC cells, and MMP1 knockdown completely blocks the proliferation and invasion phenotype caused by CIC deficiency, establishing a CIC–ETV4–MMP1 regulatory axis.","method":"CIC overexpression/knockdown in vitro and in vivo, ETV4 and MMP1 knockdown, proliferation/invasion assays, luciferase reporter assays","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 2 — epistatic rescue experiment (MMP1 KD completely reverses CIC-KD phenotype) establishes pathway order; 76 citations","pmids":["29251790"],"is_preprint":false},{"year":2018,"finding":"FICZ (an endogenous AHR ligand) upregulates MMP1 expression in normal human dermal fibroblasts through AHR-dependent MEK/ERK signaling; AHR knockdown and MEK/ERK inhibitors block FICZ-induced MMP1 upregulation, while JNK/p38 inhibitors are additionally required for UVB-induced MMP1.","method":"AHR-knockdown NHDFs, selective MAPK inhibitors, MEK/ERK phosphorylation (Western blot), ELISA, qRT-PCR","journal":"Journal of dermatological science","confidence":"High","confidence_rationale":"Tier 2 — AHR knockdown plus selective kinase inhibitors distinguishing two upstream induction pathways","pmids":["29703420"],"is_preprint":false},{"year":2018,"finding":"Gasdermin C (GSDMC), induced by UV irradiation at late time points, is required for UV-induced MMP-1 expression (but not MMP-3 or MMP-9) in human skin keratinocytes; GSDMC overexpression increases ERK and JNK activation, and inhibition of ERK or JNK suppresses GSDMC-induced MMP-1 expression.","method":"GSDMC knockdown and overexpression in HaCaT and primary keratinocytes, ERK/JNK inhibitors, qRT-PCR, Western blot","journal":"Journal of dermatological science","confidence":"Medium","confidence_rationale":"Tier 2 — loss- and gain-of-function with kinase inhibitor pathway dissection; single lab, single study","pmids":["29428815"],"is_preprint":false},{"year":2019,"finding":"ETV4 directly activates MMP1 transcription in NSCLC cells; ETV4 overexpression increases MMP1 mRNA and protein, and luciferase reporter assays confirm direct ETV4 regulation of the MMP1 promoter; inhibition of MMP1 partially abolishes ETV4-driven cell proliferation and migration.","method":"ETV4 gain/loss-of-function, microarray, luciferase reporter assays, MMP1 knockdown rescue experiments, in vivo xenograft","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter regulation confirmed by luciferase assay; partial rescue by MMP1 inhibition validates functional significance","pmids":["31670855"],"is_preprint":false},{"year":2020,"finding":"EGR-1 (early growth response protein 1) directly binds to an EGR-1 binding sequence (EBS) in the proximal MMP1 promoter and transactivates MMP1 in response to TNFα in keratinocytes; EGR-1 silencing reduces TNFα-induced MMP-1 expression, and mutation of the EBS abolishes EGR-1-mediated promoter activation. All three MAPKs (ERK1/2, JNK, p38) mediate TNFα-induced MMP-1 via EGR-1 upregulation.","method":"Promoter deletion analysis, luciferase reporter assays, EGR-1 siRNA, EGR-1 overexpression, EBS site-directed mutagenesis, MAPK inhibitors, Western blot","journal":"BMB reports","confidence":"High","confidence_rationale":"Tier 1-2 — promoter mutagenesis combined with siRNA knockdown and overexpression validates direct EGR-1→MMP1 transcriptional activation","pmids":["32317080"],"is_preprint":false},{"year":2021,"finding":"MMP1 secreted by LCC tumor cells induces premature senescence in pulmonary fibroblasts (via PAR-1 and oxidative stress), and senescent fibroblasts in turn drive LCC cell growth and invasion; MMP1 knockdown prevents fibroblast senescence and tumor promotion in cell culture and mouse models, and MMP1 combined with TGF-β1 is sufficient to induce fibroblast senescence.","method":"MMP1 overexpression/knockdown in LCC cell lines, co-culture senescence assays, in vivo mouse models, PAR-1 inhibition, oxidative stress assays","journal":"Cancer letters","confidence":"High","confidence_rationale":"Tier 2 — gain/loss-of-function with defined senescence phenotype, PAR-1 mechanism, and in vivo validation","pmids":["33684534"],"is_preprint":false},{"year":2021,"finding":"TAM-derived MMP1 activates PAR-1 on colon cancer cells to trigger MAPK/Erk signaling, accelerating cell cycle progression (G0/G1 to S and G2/M) and activating cdc25a/CDK4-cyclin D1 and p21/cdc2-cyclin B1 complexes via c-Myc and ETV4; ETV4 in turn binds the MMP1 promoter to form a positive feedback loop (MMP1/PAR1/Erk1/2/ETV4/MMP1).","method":"Exogenous MMP1 treatment, PAR-1 inhibition, MEK/ERK inhibitors, cell cycle analysis, co-IP, ChIP for ETV4 at MMP1 promoter, in vitro/in vivo experiments","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 — PAR-1 signaling and ChIP confirmed, positive feedback loop established; single lab study","pmids":["34753916"],"is_preprint":false},{"year":2022,"finding":"RUNX2 directly binds to specific motifs in the MMP1 promoter and activates MMP1 transcription in triple-negative breast cancer, as confirmed by ChIP and qRT-PCR; RUNX2 silencing suppresses MMP1 expression and reduces proliferation, migration, invasion, chemoresistance, and in vivo tumorigenicity.","method":"RUNX2 siRNA knockdown, RNA-sequencing, ChIP assay at MMP1 promoter, qRT-PCR, in vivo xenograft tumorigenicity","journal":"Frontiers in oncology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirms direct promoter binding; functional phenotypes consistent; single lab","pmids":["36483054"],"is_preprint":false},{"year":2022,"finding":"NAT10 promotes MMP1 mRNA stability through N4-acetylcytidine (ac4C) acetylation of MMP1 mRNA; NAT10 knockdown reduces both total and ac4C-acetylated MMP1 mRNA and decreases MMP1 mRNA stability, impairing OSCC cell proliferation, migration, invasion, and in vivo tumorigenesis in an MMP1-dependent manner.","method":"NAT10 knockdown (lentivirus), acRIP (acetylated RNA immunoprecipitation sequencing), MMP1 mRNA stability assays, xenograft experiments, rescue by MMP1 overexpression","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 — RNA modification confirmed by acRIP and mRNA stability assay; MMP1-dependent rescue validates functional link; single lab","pmids":["37705232"],"is_preprint":false},{"year":2017,"finding":"MMP1 mRNA is selectively packaged into cancer-derived extracellular vesicles (EVs) from highly metastatic ovarian cancer cells; EV transfer delivers intact MMP1 mRNA to mesothelial cells, upregulating MMP1 expression, inducing apoptosis in mesothelial cells, and facilitating destruction of the peritoneal barrier for peritoneal dissemination.","method":"Whole transcriptome analysis, EV isolation and characterization, MMP1 mRNA detection in EVs by qRT-PCR, in vitro apoptosis assays, in vivo peritoneal dissemination model, MMP1 mRNA detection in patient ascites EVs","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — EV-mediated mRNA delivery confirmed with functional consequence in vitro and in vivo; novel mechanism, single lab study","pmids":["28262727"],"is_preprint":false}],"current_model":"MMP1 (interstitial collagenase-1) is a secreted zinc-dependent endoprotease whose proenzyme is activated extracellularly by enzymes including mast cell chymase (cleaving Leu83–Thr84) and MMP-7; its catalytic domain structure, determined by X-ray crystallography, contains a catalytic zinc, a structural zinc, and a calcium ion, with an exon-5-encoded loop that determines collagen substrate specificity and inhibitor selectivity; MMP1 cleaves fibrillar collagens (types I, II, III), IGFBP-3, MCP chemokines (generating CCR antagonists), LAMA5, and the EGF-like ligands AREG/HB-EGF/TGFα (releasing them from tumor cell surfaces to drive osteoclastogenesis); MMP1 cleaves and activates PAR1 on stromal and cancer cells, generating Ca2+ signals that drive cell migration and invasion; its transcription is induced downstream of AP-1 (c-Fos/c-Jun), NF-κB, C/EBP-β, ETS1/2, GATA3, EGR-1, and ETV4 in response to cytokines (IL-1β, TNFα, IL-17), UV-induced DNA damage, EGFR/ERK signaling, and Cdc42 suppression of ERK, and is suppressed by Akt, RUNX2, Slug, miR-203, miR-526b, miR-145, and ac4C RNA modification (via NAT10); MMP1 promotes tumor invasion, metastasis, angiogenesis (through a shear-stress/MMP1/sprouting axis and LAMA5 fragmentation via integrin αvβ3), and induces fibroblast senescence via PAR-1 and oxidative stress to create a tumor-promoting microenvironment."},"narrative":{"teleology":[{"year":1986,"claim":"Cloning and sequence determination of MMP1 established it as a preproenzyme with a signal peptide and an 81-residue propeptide removed during activation, providing the molecular framework for understanding zymogen processing.","evidence":"cDNA cloning and full-length sequencing of human skin fibroblast collagenase mRNA","pmids":["3009463"],"confidence":"High","gaps":["Activation mechanism (which proteases cleave the propeptide) was not yet identified","Three-dimensional structure unknown"]},{"year":1986,"claim":"Identification of a TPA-inducible 32-bp enhancer element in the MMP1 promoter revealed that MMP1 is transcriptionally regulated by phorbol ester signaling, founding the study of MMP1 transcriptional control.","evidence":"Deletion mutagenesis of the MMP1 5′-flanking region with transfection reporter assays","pmids":["3037355"],"confidence":"High","gaps":["Transcription factors binding this element were not identified","Physiological inducers beyond TPA not yet explored"]},{"year":1994,"claim":"Crystal structure determination of the MMP1 catalytic domain revealed the catalytic zinc, structural zinc, and calcium ion, and showed a thermolysin/astacin-like fold, providing the structural basis for inhibitor design and understanding catalytic mechanism.","evidence":"X-ray crystallography at 2.4 Å of inhibitor-bound MMP1 catalytic domain","pmids":["8278810"],"confidence":"High","gaps":["Full-length structure with hemopexin domain not determined","Structural basis for collagen specificity not resolved at this stage"]},{"year":1994,"claim":"Identification of mast cell chymase and subsequently MMP-7 as physiological activators of pro-MMP1, with precise cleavage sites mapped, resolved how the zymogen is processed extracellularly and revealed cascade activation among MMPs.","evidence":"In vitro activation assays with purified chymase and MMP-7, N-terminal sequencing of cleavage products","pmids":["8027075","7896811"],"confidence":"High","gaps":["In vivo relevance of each activation pathway in specific tissues not established","Whether other proteases contribute to activation in inflammatory contexts"]},{"year":1994,"claim":"Demonstration that MMP1 cleaves IGFBP-3 expanded its substrate repertoire beyond collagens and implicated MMP1 in growth factor bioavailability regulation.","evidence":"Reconstituted in vitro cleavage with recombinant enzymes and N-terminal sequencing of cleavage products","pmids":["7523391"],"confidence":"High","gaps":["In vivo significance for IGF signaling not confirmed","Other IGFBP family members as substrates not tested"]},{"year":2000,"claim":"Discovery that MMP1 cleaves MCP-3 to generate CC chemokine receptor antagonists revealed an anti-inflammatory function, showing MMP1 shapes immune cell recruitment beyond simple ECM remodeling.","evidence":"In vitro cleavage of recombinant chemokines by multiple MMPs, receptor-binding and chemotaxis assays, in vivo paw-edema model","pmids":["10947989","12149192"],"confidence":"High","gaps":["Relative importance of MMP1 vs other collagenases for in vivo chemokine processing unclear","Whether MMP1 cleaves other chemokine families not tested"]},{"year":2001,"claim":"Exon-5 domain swap experiments established that the exon-5-encoded loop is the structural determinant of MMP1's collagenolytic specificity and TIMP selectivity, answering why MMP1 but not MMP-3 cleaves fibrillar collagens.","evidence":"MMP-1/MMP-3 chimeric enzymes tested on type I collagen, synthetic substrates, and TIMPs","pmids":["11248710"],"confidence":"High","gaps":["Atomic-resolution mechanism of collagen unwinding by the hemopexin domain not resolved","Whether exon-5 alone is sufficient for collagenolytic activity on type II/III collagens not tested"]},{"year":2005,"claim":"MMP1 was identified as a protease agonist of PAR1, establishing a non-ECM signaling function whereby MMP1-mediated PAR1 cleavage triggers Ca²⁺ signals that drive breast carcinoma invasion—a paradigm shift from purely ECM-degrading roles.","evidence":"PAR1 cleavage assays, Ca²⁺ signaling, migration assays, and breast cancer xenograft model","pmids":["15707890"],"confidence":"High","gaps":["Precise PAR1 cleavage site by MMP1 vs thrombin-mediated activation and downstream signal divergence not fully resolved","Whether PAR1 activation by MMP1 occurs in non-cancer physiological contexts"]},{"year":2005,"claim":"Cdc42 was placed as an upstream negative regulator of MMP1 via ERK suppression, establishing that Rho-family GTPases control MMP1 expression through MAPK pathways in fibroblasts and keratinocytes.","evidence":"Cdc42 siRNA with rescue, Rac1 co-silencing, MEK/ERK inhibitors in dermal fibroblasts; later confirmed in collagen-stimulated keratinocytes","pmids":["15728253","24352036"],"confidence":"High","gaps":["Direct Cdc42 targets upstream of ERK not identified","Whether Cdc42-MMP1 axis operates in vivo tissue remodeling unknown"]},{"year":2006,"claim":"Drosophila genetic epistasis showed that Mmp1 is the critical JNK/Fos effector of polarity-loss-driven invasion in cooperative tumors, providing in vivo genetic validation of MMP1 as a tumor invasion executor.","evidence":"mmp1 RNAi, TIMP overexpression in Drosophila imaginal disc clones with scribble/Ras tumors","pmids":["17082773"],"confidence":"High","gaps":["Direct mammalian ortholog relevance of this Drosophila JNK-Mmp1 pathway not validated","Mmp1 substrates in Drosophila invasion not identified in this study"]},{"year":2007,"claim":"Combined MMP1/MMP2 loss-of-function in breast cancer xenografts demonstrated that MMP1 is required for intravasation, extravasation, and lung metastasis seeding, defining MMP1 as a rate-limiting protease for the metastatic cascade.","evidence":"Genetic knockdown and pharmacological inhibition of MMP1/MMP2 in breast cancer xenograft and lung metastasis models","pmids":["17429393"],"confidence":"High","gaps":["Individual contributions of MMP1 vs MMP2 to each metastatic step not fully separated","Host-derived vs tumor-derived MMP1 contributions unclear"]},{"year":2007,"claim":"Mapping the transcriptional cascade upstream of MMP1 in cardiac fibroblasts showed that IL-17 induces MMP1 through p38/ERK → AP-1 + NF-κB + C/EBP-β, establishing multi-transcription-factor convergence as the mechanism for cytokine-driven MMP1 induction.","evidence":"siRNA, antisense, dominant-negatives, pharmacological kinase inhibitors, EMSA, and reporter assays in primary cardiac fibroblasts","pmids":["17921324"],"confidence":"High","gaps":["Relative quantitative contribution of each transcription factor to total MMP1 output not determined","Whether this multi-factor module applies identically in other cell types"]},{"year":2008,"claim":"UV-induced DNA damage in keratinocytes was identified as the primary trigger for paracrine MMP1 induction in the dermis, establishing an epidermis-to-dermis signaling pathway for photoaging-associated collagen degradation.","evidence":"DNA repair enzyme (photolyase) application to UV-irradiated keratinocytes, conditioned medium transfer to fibroblasts","pmids":["18459971"],"confidence":"High","gaps":["Identity of the soluble paracrine mediator from keratinocytes not determined","In vivo relevance beyond ex vivo skin models not confirmed"]},{"year":2009,"claim":"MMP1 was shown to release membrane-tethered EGF-like ligands (AREG, HB-EGF, TGFα) from tumor cell surfaces, activating osteoblast EGFR to suppress OPG and drive osteolytic bone metastasis—establishing MMP1 as a sheddase with paracrine signaling consequences.","evidence":"siRNA knockdown of MMP1/ADAMTS1, EGFR inhibitors, EGF-like ligand release assays, osteoclast differentiation assays, in vivo bone metastasis models","pmids":["19608765"],"confidence":"High","gaps":["Whether MMP1 directly cleaves all three EGF-like ligands or acts via intermediate proteases","Relative contribution of MMP1 vs ADAMTS1 to ligand shedding"]},{"year":2014,"claim":"MMP1 was identified as a required effector of shear-stress-induced endothelial sprouting, linking hemodynamic forces to angiogenesis through MMP1 upregulation.","evidence":"Microfluidic shear stress devices with siRNA knockdown of MMP1 and 3D sprouting assays","pmids":["24843171"],"confidence":"High","gaps":["Mechanotransduction pathway connecting shear stress to MMP1 transcription not identified","Relevant MMP1 substrates in sprouting angiogenesis not defined"]},{"year":2015,"claim":"Post-transcriptional regulation of MMP1 was established by miR-203 (via NF-κB) and miR-526b (direct 3′UTR targeting), expanding the regulatory landscape beyond transcriptional control.","evidence":"miR-203 overexpression with NF-κB inhibition in RA fibroblasts; 3′UTR luciferase reporter mutagenesis for miR-526b","pmids":["21279994","26292968"],"confidence":"High","gaps":["Whether miR-203 directly targets MMP1 3′UTR or acts indirectly via NF-κB pathway modulation","In vivo relevance of miR-526b regulation not established"]},{"year":2016,"claim":"Identification of LAMA5 as an MMP1 substrate whose proteolytic fragments promote angiogenesis via integrin αvβ3 defined a novel extracellular signaling axis connecting MMP1-mediated ECM cleavage to vascular growth.","evidence":"Mass spectrometry substrate identification, integrin αvβ3 blocking antibody, MMP1 siRNA with xenograft tumor volume measurement","pmids":["27324842"],"confidence":"High","gaps":["Specific LAMA5 cleavage sites not mapped","Whether other laminin subunits are also MMP1 substrates"]},{"year":2017,"claim":"EV-packaged MMP1 mRNA from metastatic ovarian cancer cells was shown to induce mesothelial cell apoptosis, revealing a non-canonical mechanism of MMP1 delivery for peritoneal metastasis.","evidence":"EV transcriptome analysis, qRT-PCR of MMP1 mRNA in EVs, in vitro apoptosis assays, in vivo peritoneal dissemination model","pmids":["28262727"],"confidence":"Medium","gaps":["Whether EV-delivered MMP1 mRNA is translated into functional protein in recipient cells not directly shown","Mechanism of selective MMP1 mRNA packaging into EVs unknown","Single-lab finding not independently replicated"]},{"year":2018,"claim":"The CIC–ETV4–MMP1 axis was established in hepatocellular carcinoma: CIC suppresses ETV4, which directly transactivates MMP1, and MMP1 knockdown fully rescues CIC-deficiency phenotypes, placing MMP1 as the terminal effector of this invasion-driving cascade.","evidence":"Epistatic knockdown/overexpression of CIC, ETV4, and MMP1 with luciferase reporter assays and in vivo xenograft","pmids":["29251790"],"confidence":"High","gaps":["Whether CIC–ETV4–MMP1 axis operates in non-HCC cancers","Direct ETV4 binding sites on MMP1 promoter not mapped by ChIP in this study"]},{"year":2021,"claim":"MMP1 was shown to induce premature senescence in pulmonary fibroblasts through PAR-1 and oxidative stress, and senescent fibroblasts reciprocally promoted tumor growth, establishing MMP1 as a remodeler of the tumor microenvironment beyond direct ECM degradation.","evidence":"MMP1 overexpression/knockdown, co-culture senescence assays, PAR-1 inhibition, oxidative stress measurement, in vivo mouse models","pmids":["33684534"],"confidence":"High","gaps":["Specific PAR-1 downstream signaling events leading to senescence not fully mapped","Whether this senescence-inducing function operates in non-pulmonary tissue stroma"]},{"year":2021,"claim":"A positive feedback loop (MMP1/PAR1/ERK/ETV4/MMP1) was identified in tumor-associated macrophage–colon cancer cell communication, where TAM-derived MMP1 activates PAR1 to drive cell cycle progression and ETV4 feeds back to sustain MMP1 transcription.","evidence":"Exogenous MMP1, PAR-1/MEK inhibitors, ChIP for ETV4 at MMP1 promoter, cell cycle analysis, in vivo experiments","pmids":["34753916"],"confidence":"Medium","gaps":["Quantitative contribution of the feedback loop vs unidirectional signaling not measured","Single-lab study; independent replication needed","Whether loop operates in non-colon cancer contexts"]},{"year":2022,"claim":"NAT10-mediated ac4C modification of MMP1 mRNA was identified as a post-transcriptional stabilization mechanism promoting OSCC invasion, revealing epitranscriptomic control of MMP1 expression.","evidence":"NAT10 knockdown, acRIP-seq, MMP1 mRNA stability assays, MMP1 overexpression rescue, xenograft experiments","pmids":["37705232"],"confidence":"Medium","gaps":["Specific ac4C sites on MMP1 mRNA not mapped at nucleotide resolution","Whether other epitranscriptomic modifications regulate MMP1 mRNA","Single-lab finding not independently confirmed"]},{"year":null,"claim":"Key unresolved questions include the identity of the paracrine factor mediating UV-keratinocyte-to-fibroblast MMP1 induction, the structural mechanism by which the hemopexin domain cooperates with the catalytic domain to unwind triple-helical collagen, and whether the EV-mediated MMP1 mRNA transfer mechanism generalizes across cancer types.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length MMP1 structure with collagen substrate","Paracrine UV mediator unidentified","EV-mediated MMP1 mRNA transfer lacks independent replication"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3,4,5,6,7,8,9,15,26]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[2,6,8]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,6,7,9,15,26]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[6,26]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[38]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[6,8,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,15,34,35]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,15,29,34]}],"complexes":[],"partners":["PAR1","TIMP1","TIMP2","MMP7","ETV4","LAMA5","IGFBP3"],"other_free_text":[]},"mechanistic_narrative":"MMP1 (interstitial collagenase) is a secreted zinc-dependent endopeptidase that initiates degradation of fibrillar collagens (types I, II, III) and cleaves additional extracellular substrates including IGFBP-3, MCP chemokines, LAMA5, and EGF-like ligands (AREG, HB-EGF, TGFα), thereby modulating IGF bioavailability, chemokine signaling, angiogenesis, and osteoclastogenesis [PMID:10419448, PMID:7523391, PMID:10947989, PMID:27324842, PMID:19608765]. MMP1 also functions as a protease agonist of PAR1, generating intracellular Ca²⁺ signals that drive tumor cell migration, invasion, and fibroblast senescence in the tumor microenvironment [PMID:15707890, PMID:33684534]. The proenzyme is activated extracellularly by mast cell chymase (Leu83–Thr84 cleavage) and MMP-7 (Gln80–Phe81 cleavage), and its catalytic domain—containing a catalytic zinc, structural zinc, and calcium—uses an exon-5-encoded loop to confer collagen substrate specificity [PMID:8027075, PMID:7896811, PMID:8278810, PMID:11248710]. MMP1 transcription is induced by AP-1 (c-Fos/c-Jun), NF-κB, C/EBP-β, ETS1/2, EGR-1, ETV4, and RUNX2 downstream of cytokines, UV-induced DNA damage, and ERK/JNK signaling, and is post-transcriptionally regulated by miR-526b and NAT10-mediated ac4C mRNA modification [PMID:3037355, PMID:17921324, PMID:32317080, PMID:29251790, PMID:26292968, PMID:37705232]."},"prefetch_data":{"uniprot":{"accession":"P03956","full_name":"Interstitial collagenase","aliases":["Fibroblast collagenase","Matrix metalloproteinase-1","MMP-1"],"length_aa":469,"mass_kda":54.0,"function":"Cleaves collagens of types I, II, and III at one site in the helical domain. Also cleaves collagens of types VII and X (PubMed:1645757, PubMed:2153297, PubMed:2557822). In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity (PubMed:16807369)","subcellular_location":"Secreted, extracellular space, extracellular matrix","url":"https://www.uniprot.org/uniprotkb/P03956/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MMP1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MMP1","total_profiled":1310},"omim":[{"mim_id":"619427","title":"ZINC FINGER PROTEIN 410; ZNF410","url":"https://www.omim.org/entry/619427"},{"mim_id":"613510","title":"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MAPK AND MTOR ACTIVATOR 1; LAMTOR1","url":"https://www.omim.org/entry/613510"},{"mim_id":"613155","title":"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1; MDDGB1","url":"https://www.omim.org/entry/613155"},{"mim_id":"612111","title":"TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8; TNFAIP8","url":"https://www.omim.org/entry/612111"},{"mim_id":"610504","title":"PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM","url":"https://www.omim.org/entry/610504"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"gallbladder","ntpm":70.7},{"tissue":"stomach 1","ntpm":44.2},{"tissue":"urinary bladder","ntpm":48.6}],"url":"https://www.proteinatlas.org/search/MMP1"},"hgnc":{"alias_symbol":[],"prev_symbol":["CLG"]},"alphafold":{"accession":"P03956","domains":[{"cath_id":"3.40.390.10","chopping":"114-261","consensus_level":"high","plddt":97.3278,"start":114,"end":261},{"cath_id":"2.110.10.10","chopping":"287-460","consensus_level":"high","plddt":96.9319,"start":287,"end":460}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P03956","model_url":"https://alphafold.ebi.ac.uk/files/AF-P03956-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P03956-F1-predicted_aligned_error_v6.png","plddt_mean":91.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MMP1","jax_strain_url":"https://www.jax.org/strain/search?query=MMP1"},"sequence":{"accession":"P03956","fasta_url":"https://rest.uniprot.org/uniprotkb/P03956.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P03956/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P03956"}},"corpus_meta":[{"pmid":"17082773","id":"PMC_17082773","title":"JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17082773","citation_count":332,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28262727","id":"PMC_28262727","title":"Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28262727","citation_count":259,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19608765","id":"PMC_19608765","title":"ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis.","date":"2009","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/19608765","citation_count":247,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33391541","id":"PMC_33391541","title":"Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33391541","citation_count":146,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18459971","id":"PMC_18459971","title":"UV-induced DNA damage initiates release of MMP-1 in human skin.","date":"2008","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/18459971","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26600542","id":"PMC_26600542","title":"High MMP-1, MMP-2, and MMP-9 protein levels in osteoarthritis.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26600542","citation_count":133,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27130665","id":"PMC_27130665","title":"MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma.","date":"2016","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/27130665","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10670469","id":"PMC_10670469","title":"Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts.","date":"2000","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/10670469","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16455304","id":"PMC_16455304","title":"Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression.","date":"2006","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16455304","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15930517","id":"PMC_15930517","title":"Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts.","date":"2005","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15930517","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18625714","id":"PMC_18625714","title":"Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18625714","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29251790","id":"PMC_29251790","title":"Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.","date":"2018","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/29251790","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19056796","id":"PMC_19056796","title":"Cordycepin inhibits IL-1beta-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts.","date":"2009","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19056796","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18342502","id":"PMC_18342502","title":"Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial.","date":"2008","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/18342502","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12873541","id":"PMC_12873541","title":"Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure.","date":"2003","source":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/12873541","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18323784","id":"PMC_18323784","title":"Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts.","date":"2008","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/18323784","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25520167","id":"PMC_25520167","title":"Mmp1 and Mmp2 cooperatively induce Drosophila fat body cell dissociation with distinct roles.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25520167","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19550047","id":"PMC_19550047","title":"MMP-1 polymorphism and its relationship to pathological processes.","date":"2009","source":"Journal of biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/19550047","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18366705","id":"PMC_18366705","title":"Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis.","date":"2008","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18366705","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33135346","id":"PMC_33135346","title":"TCONS_00012883 promotes proliferation and metastasis via DDX3/YY1/MMP1/PI3K-AKT axis in colorectal cancer.","date":"2020","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33135346","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31670855","id":"PMC_31670855","title":"ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.","date":"2019","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31670855","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15728253","id":"PMC_15728253","title":"Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15728253","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28334049","id":"PMC_28334049","title":"MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28334049","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30800206","id":"PMC_30800206","title":"Dihydrocaffeic Acid Prevents UVB-Induced Oxidative Stress Leading to the Inhibition of Apoptosis and MMP-1 Expression via p38 Signaling Pathway.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/30800206","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20089870","id":"PMC_20089870","title":"Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.","date":"2010","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/20089870","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18597092","id":"PMC_18597092","title":"Expression of MMP-1 in cartilage and synovium of experimentally induced rabbit ACLT traumatic osteoarthritis: immunohistochemical study.","date":"2008","source":"Rheumatology international","url":"https://pubmed.ncbi.nlm.nih.gov/18597092","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33684534","id":"PMC_33684534","title":"MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/33684534","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12009332","id":"PMC_12009332","title":"Reduction of cytokine-induced expression and activity of MMP-1 and MMP-13 by mechanical strain in MH7A rheumatoid synovial cells.","date":"2002","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12009332","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11161388","id":"PMC_11161388","title":"The clinical significance of MMP-1 expression in oesophageal carcinoma.","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11161388","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16862557","id":"PMC_16862557","title":"Upregulation of matrix metalloproteinase (MMP)-1 and its activator MMP-3 of human osteoblast by uniaxial cyclic stimulation.","date":"2007","source":"Journal of biomedical materials research. Part B, Applied biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/16862557","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21440529","id":"PMC_21440529","title":"ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21440529","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29428815","id":"PMC_29428815","title":"Gasdermin C is induced by ultraviolet light and contributes to MMP-1 expression via activation of ERK and JNK pathways.","date":"2018","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/29428815","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24058270","id":"PMC_24058270","title":"Stimulation of MMP-1 and CCL2 by NAMPT in PDL cells.","date":"2013","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/24058270","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35163100","id":"PMC_35163100","title":"CD26 Induces Colorectal Cancer Angiogenesis and Metastasis through CAV1/MMP1 Signaling.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35163100","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16459052","id":"PMC_16459052","title":"TAK1 downregulation reduces IL-1beta induced expression of MMP13, MMP1 and TNF-alpha.","date":"2005","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/16459052","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28961241","id":"PMC_28961241","title":"Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28961241","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31115512","id":"PMC_31115512","title":"MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer.","date":"2019","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31115512","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34753916","id":"PMC_34753916","title":"Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting role.","date":"2021","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34753916","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26992058","id":"PMC_26992058","title":"Kynurenine Modulates MMP-1 and Type-I Collagen Expression Via Aryl Hydrocarbon Receptor Activation in Dermal Fibroblasts.","date":"2016","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26992058","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35205603","id":"PMC_35205603","title":"HPRT1 Promotes Chemoresistance in Oral Squamous Cell Carcinoma via Activating MMP1/PI3K/Akt Signaling Pathway.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35205603","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29048269","id":"PMC_29048269","title":"An improved collagen zymography approach for evaluating the collagenases MMP-1, MMP-8, and MMP-13.","date":"2017","source":"BioTechniques","url":"https://pubmed.ncbi.nlm.nih.gov/29048269","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33226171","id":"PMC_33226171","title":"Praeruptorin A reduces metastasis of human hepatocellular carcinoma cells by targeting ERK/MMP1 signaling pathway.","date":"2020","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/33226171","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19591174","id":"PMC_19591174","title":"NAG7 promotes human nasopharyngeal carcinoma invasion through inhibition of estrogen receptor alpha and up-regulation of JNK2/AP-1/MMP1 pathways.","date":"2009","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19591174","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27127689","id":"PMC_27127689","title":"Assessment of MMP-1, MMP-8 and TIMP-2 in experimental periodontitis treated with kaempferol.","date":"2016","source":"Journal of periodontal & implant science","url":"https://pubmed.ncbi.nlm.nih.gov/27127689","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25926075","id":"PMC_25926075","title":"Lung Adenocarcinomas and Lung Cancer Cell Lines Show Association of MMP-1 Expression With STAT3 Activation.","date":"2015","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25926075","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21531813","id":"PMC_21531813","title":"Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.","date":"2011","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/21531813","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29703420","id":"PMC_29703420","title":"Tryptophan photo-product FICZ upregulates AHR/MEK/ERK-mediated MMP1 expression: Implications in anti-fibrotic phototherapy.","date":"2018","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/29703420","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14977049","id":"PMC_14977049","title":"Induction of MMP-10 and MMP-1 in a squamous cell carcinoma cell line by ultraviolet radiation.","date":"2004","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14977049","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26298287","id":"PMC_26298287","title":"Methotrexate modulates the expression of MMP-1 and type 1 collagen in dermal fibroblast.","date":"2015","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26298287","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36105241","id":"PMC_36105241","title":"MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma.","date":"2022","source":"Computational and mathematical methods in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36105241","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19821768","id":"PMC_19821768","title":"A functional polymorphism in MMP1 could influence osteomyelitis development.","date":"2010","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/19821768","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23108733","id":"PMC_23108733","title":"The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse.","date":"2012","source":"International urogynecology journal","url":"https://pubmed.ncbi.nlm.nih.gov/23108733","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35267540","id":"PMC_35267540","title":"Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35267540","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27324842","id":"PMC_27324842","title":"Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27324842","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35624792","id":"PMC_35624792","title":"SOD3 Suppresses the Expression of MMP-1 and Increases the Integrity of Extracellular Matrix in Fibroblasts.","date":"2022","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35624792","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26829555","id":"PMC_26829555","title":"Leptin and Pro-Inflammatory Stimuli Synergistically Upregulate MMP-1 and MMP-3 Secretion in Human Gingival Fibroblasts.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26829555","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24352036","id":"PMC_24352036","title":"Cdc42 inhibits ERK-mediated collagenase-1 (MMP-1) expression in collagen-activated human keratinocytes.","date":"2013","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/24352036","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22469989","id":"PMC_22469989","title":"Expression of STAT3, MMP-1 and TIMP-1 in gastric cancer and correlation with pathological features.","date":"2012","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/22469989","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27653023","id":"PMC_27653023","title":"DDR2-CYR61-MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes.","date":"2016","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/27653023","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31677173","id":"PMC_31677173","title":"Matrix metalloproteinases MMP-1, MMP-2, and MMP-13 are overexpressed in primary nodular melanoma.","date":"2019","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31677173","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35444805","id":"PMC_35444805","title":"Molecular Patho-mechanisms of cervical cancer (MMP1).","date":"2022","source":"Annals of medicine and surgery (2012)","url":"https://pubmed.ncbi.nlm.nih.gov/35444805","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36305146","id":"PMC_36305146","title":"Wogonin Restrains the Malignant Progression of Lung Cancer Through Modulating MMP1 and PI3K/AKT Signaling Pathway.","date":"2023","source":"Protein and peptide letters","url":"https://pubmed.ncbi.nlm.nih.gov/36305146","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34062170","id":"PMC_34062170","title":"Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo.","date":"2021","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34062170","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28637905","id":"PMC_28637905","title":"p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC.","date":"2017","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/28637905","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29977178","id":"PMC_29977178","title":"The Effect of Pulsed Electric Field on Expression of ECM proteins: Collagen, Elastin, and MMP1 in Human Dermal Fibroblasts.","date":"2018","source":"Journal of electroanalytical chemistry (Lausanne, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/29977178","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10586373","id":"PMC_10586373","title":"Direct action by doxycycline against canine osteosarcoma cell proliferation and collagenase (MMP-1) activity in vitro.","date":"1999","source":"In vivo (Athens, Greece)","url":"https://pubmed.ncbi.nlm.nih.gov/10586373","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21244711","id":"PMC_21244711","title":"MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms.","date":"2011","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21244711","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12046073","id":"PMC_12046073","title":"Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats.","date":"2002","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/12046073","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31344439","id":"PMC_31344439","title":"Platelet-secreted CCL3 and its receptor CCR5 promote invasive and migratory abilities of anaplastic thyroid carcinoma cells via MMP-1.","date":"2019","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/31344439","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38320998","id":"PMC_38320998","title":"IL-8 activates fibroblasts to promote the invasion of HNSCC cells via STAT3-MMP1.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38320998","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20201953","id":"PMC_20201953","title":"Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts.","date":"2010","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20201953","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15240110","id":"PMC_15240110","title":"Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15240110","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24995609","id":"PMC_24995609","title":"MMP-1 promoter genotype and haplotype association with posterior tibial tendinopathy.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24995609","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25863779","id":"PMC_25863779","title":"Activity of MMP1 and MMP13 and amino acid metabolism in patients with alcoholic liver cirrhosis.","date":"2015","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/25863779","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9409309","id":"PMC_9409309","title":"cAMP involvement in the expression of MMP-2 and MT-MMP1 metalloproteinases in human endothelial cells.","date":"1997","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9409309","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21835828","id":"PMC_21835828","title":"Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.","date":"2011","source":"Japanese journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21835828","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29670668","id":"PMC_29670668","title":"Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (MMP1, MMP2, MMP3, and MMP9) Genes with Preeclampsia.","date":"2018","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/29670668","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31124581","id":"PMC_31124581","title":"Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL).","date":"2019","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/31124581","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26505388","id":"PMC_26505388","title":"Resveratrol could reverse the expression of SIRT1 and MMP-1 in vitro.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26505388","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17342265","id":"PMC_17342265","title":"Inhibitory effects of natural plants of Jeju Island on elastase and MMP-1 expression.","date":"2007","source":"Journal of cosmetic science","url":"https://pubmed.ncbi.nlm.nih.gov/17342265","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31350707","id":"PMC_31350707","title":"IRF-2 Inhibits Gastric Cancer Invasion and Migration by Down-Regulating MMP-1.","date":"2019","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31350707","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29236309","id":"PMC_29236309","title":"Leptin induces MMP1/13 and ADAMTS 4 expressions through bone morphogenetic protein-2 autocrine effect in human chondrocytes.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29236309","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26292968","id":"PMC_26292968","title":"miR-526b targets 3' UTR of MMP1 mRNA.","date":"2015","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26292968","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24820961","id":"PMC_24820961","title":"A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (MMP1) in endometrial cancer.","date":"2014","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/24820961","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17094476","id":"PMC_17094476","title":"Kinetics of MMP-1 and MMP-3 produced by mast cells and macrophages in liver fibrogenesis of rat.","date":"2006","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17094476","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19782069","id":"PMC_19782069","title":"RhoB enhances migration and MMP1 expression of prostate cancer DU145.","date":"2009","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19782069","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11248710","id":"PMC_11248710","title":"The role of exon 5 in fibroblast collagenase (MMP-1) substrate specificity and inhibitor selectivity.","date":"2001","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11248710","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36483054","id":"PMC_36483054","title":"RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36483054","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19552796","id":"PMC_19552796","title":"Exercise-induced up-regulation of MMP-1 and IL-8 genes in endurance horses.","date":"2009","source":"BMC physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19552796","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25854159","id":"PMC_25854159","title":"Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis.","date":"2015","source":"Zeitschrift fur Rheumatologie","url":"https://pubmed.ncbi.nlm.nih.gov/25854159","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37705232","id":"PMC_37705232","title":"N-acetyltransferase 10 promotes the progression of oral squamous cell carcinoma through N4-acetylcytidine RNA acetylation of MMP1 mRNA.","date":"2023","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/37705232","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32317080","id":"PMC_32317080","title":"Transcription factor EGR-1 transactivates the MMP1 gene promoter in response to TNFα in HaCaT keratinocytes.","date":"2020","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/32317080","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36789689","id":"PMC_36789689","title":"ZNF3 regulates proliferation, migration and invasion through MMP1 and TWIST in colorectal cancer.","date":"2022","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/36789689","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33816223","id":"PMC_33816223","title":"PLAU1 Facilitated Proliferation, Invasion, and Metastasis via Interaction With MMP1 in Head and Neck Squamous Carcinoma.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33816223","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14519487","id":"PMC_14519487","title":"MMP-1 and MMP-2 expression in uterine leiomyosarcoma and correlation with different clinicopathologic parameters.","date":"2003","source":"Journal of the Society for Gynecologic Investigation","url":"https://pubmed.ncbi.nlm.nih.gov/14519487","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36577251","id":"PMC_36577251","title":"COL8A1 enhances the invasion/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36577251","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35358680","id":"PMC_35358680","title":"The miR-145-MMP1 axis is a critical regulator for imiquimod-induced cancer stemness and chemoresistance.","date":"2022","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/35358680","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32790210","id":"PMC_32790210","title":"UVA influenced the SIRT1-miR-27a-5p-SMAD2-MMP1/COL1/BCL2 axis in human skin primary fibroblasts.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32790210","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36142401","id":"PMC_36142401","title":"Expression of Polyamine Oxidase in Fibroblasts Induces MMP-1 and Decreases the Integrity of Extracellular Matrix.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36142401","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22819631","id":"PMC_22819631","title":"Suture compression induced bone resorption with intensified MMP-1 and 13 expressions.","date":"2012","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/22819631","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10419448","id":"PMC_10419448","title":"Matrix metalloproteinases.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10419448","citation_count":3561,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8609233","id":"PMC_8609233","title":"Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.","date":"1996","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8609233","citation_count":826,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3037355","id":"PMC_3037355","title":"12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.","date":"1987","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3037355","citation_count":745,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15707890","id":"PMC_15707890","title":"PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15707890","citation_count":664,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3009463","id":"PMC_3009463","title":"Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein.","date":"1986","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3009463","citation_count":663,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9737711","id":"PMC_9737711","title":"Matrix metalloproteinases: structures, evolution, and diversification.","date":"1998","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/9737711","citation_count":612,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10947989","id":"PMC_10947989","title":"Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10947989","citation_count":609,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11381077","id":"PMC_11381077","title":"Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11381077","citation_count":599,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17429393","id":"PMC_17429393","title":"Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17429393","citation_count":554,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18447576","id":"PMC_18447576","title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.","date":"2008","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18447576","citation_count":472,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3030290","id":"PMC_3030290","title":"Comparison of human stromelysin and collagenase by cloning and sequence analysis.","date":"1986","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/3030290","citation_count":455,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12149192","id":"PMC_12149192","title":"Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12149192","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16128620","id":"PMC_16128620","title":"Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.","date":"2005","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16128620","citation_count":406,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8226919","id":"PMC_8226919","title":"Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8226919","citation_count":372,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12706853","id":"PMC_12706853","title":"Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion.","date":"2003","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/12706853","citation_count":336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10224132","id":"PMC_10224132","title":"Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10224132","citation_count":326,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12904296","id":"PMC_12904296","title":"Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12904296","citation_count":320,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25770908","id":"PMC_25770908","title":"Matrix remodeling by MMPs during wound repair.","date":"2015","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25770908","citation_count":314,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24843171","id":"PMC_24843171","title":"Fluid shear stress threshold regulates angiogenic sprouting.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24843171","citation_count":302,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8278810","id":"PMC_8278810","title":"Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.","date":"1994","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8278810","citation_count":278,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7523391","id":"PMC_7523391","title":"Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7523391","citation_count":269,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9920899","id":"PMC_9920899","title":"Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9920899","citation_count":268,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21279994","id":"PMC_21279994","title":"Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.","date":"2011","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21279994","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8027075","id":"PMC_8027075","title":"Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8027075","citation_count":260,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7896811","id":"PMC_7896811","title":"Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7896811","citation_count":257,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17921324","id":"PMC_17921324","title":"IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.","date":"2007","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17921324","citation_count":214,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52665,"output_tokens":9308,"usd":0.148808},"stage2":{"model":"claude-opus-4-6","input_tokens":13168,"output_tokens":3723,"usd":0.238372},"total_usd":0.865704,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":66351,"output_tokens":10020,"usd":0.174677},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":14248,"output_tokens":5253,"usd":0.303847}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"The region of MMP-1 encoded by exon 5 is required for both substrate specificity (collagen vs. gelatin cleavage) and inhibitor selectivity (TIMP-1/TIMP-2 binding). A chimeric MMP-1/MMP-3 enzyme with exon 5 replaced showed drastically reduced collagenolytic activity (2.2% of wild-type) and shifted kinetics toward MMP-3 phenotype for synthetic substrates and inhibitors.\",\n      \"method\": \"Chimeric enzyme construction, in vitro collagenase activity assay, kinetics with synthetic substrates, TIMP inhibition assays (k_on, K_iapp measurements)\",\n      \"journal\": \"European Journal of Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with mutagenesis/chimera and multiple orthogonal functional assays\",\n      \"pmids\": [\"11248710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cdc42 suppresses MMP-1 expression in human skin fibroblasts by inhibiting the ERK1/2 pathway. siRNA knockdown of Cdc42 induced a 15-fold increase in MMP-1 secretion dependent on ERK1/2 activation, while Rac1 silencing reduced this effect, placing Cdc42 upstream of Rac1 and ERK in the regulation of MMP-1.\",\n      \"method\": \"siRNA knockdown of Rho GTPases, rescue with siRNA-resistant Cdc42 construct, pharmacological ERK/p38 inhibitors, ELISA, RT-PCR\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple siRNAs, rescue experiment, pharmacological inhibitors confirming pathway; single lab but orthogonal methods\",\n      \"pmids\": [\"15728253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"UV-induced MMP-1 expression in human dermal fibroblasts is mediated through ERK (MEK1) and JNK (SEK1) kinase pathways, leading to c-Fos expression and c-Jun phosphorylation/AP-1 activation, respectively. EPA inhibits both pathways and suppresses MMP-1 without antioxidant effects.\",\n      \"method\": \"Pharmacological kinase inhibitors (MEK1, SEK1), RT-PCR, Western blot, AP-1 EMSA, dose-response EPA treatment in human dermal fibroblasts\",\n      \"journal\": \"Journal of Lipid Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitors and functional readouts; single lab\",\n      \"pmids\": [\"15930517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In Drosophila, JNK signaling downstream of loss of the polarity gene scribble drives tumor cell invasion via Fos-dependent transcriptional activation of Mmp1. RNAi knockdown of Mmp1 or expression of TIMP suppressed invasion, placing Mmp1 as a required downstream effector of the JNK/Fos pathway in a Ras-cooperative tumor context.\",\n      \"method\": \"Genetic epistasis (scribble mutant + Ras activation), Mmp1 RNAi knockdown, TIMP overexpression, Fos-dependent transcription assay in Drosophila imaginal discs\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple loss-of-function experiments and defined invasive phenotype; highly cited foundational study\",\n      \"pmids\": [\"17082773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UV-induced DNA damage in keratinocytes initiates secretion of soluble mediators that signal dermal fibroblasts to release MMP-1. DNA repair enzyme treatment (T4 endonuclease V or UV endonuclease) of UV-irradiated keratinocytes prior to media transfer reduced MMP-1 mRNA and protein in unirradiated fibroblasts.\",\n      \"method\": \"Conditioned media transfer from UV-irradiated keratinocytes to unirradiated fibroblasts; photolyase-mediated DNA repair; MMP-1 mRNA and protein measurement in human skin tissue and cells\",\n      \"journal\": \"Experimental Dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based conditioned media experiment with DNA repair enzyme intervention; single lab, multiple approaches\",\n      \"pmids\": [\"18459971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Met receptor tyrosine kinase phosphorylates tyrosine at the YHPM motif of the MUC1 cytoplasmic tail (MUC1CT), facilitating nuclear localization of MUC1CT (shown by real-time confocal imaging). Phosphorylated MUC1CT enhances interaction with p53, which suppresses AP-1 transcription factor activity at the MMP1 promoter, ultimately reducing MMP1 transcription and HGF-induced invasiveness.\",\n      \"method\": \"Co-IP, Met kinase assay, site-specific phosphorylation analysis (mass spectrometry), real-time confocal imaging of nuclear localization, chromatin immunoprecipitation (MMP1 promoter), invasiveness assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including kinase assay, co-IP, live imaging, ChIP, and functional invasion assay in a single study\",\n      \"pmids\": [\"18625714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Akt kinase blockade in human dermal fibroblasts upregulates MMP-1 production and reverses TGF-β-mediated inhibition of MMP1 gene expression. Pharmacological Akt inhibitors, siRNA, and dominant-negative Akt mutant all produce this effect, while SSc (systemic sclerosis) fibroblasts show heightened sensitivity.\",\n      \"method\": \"Pharmacological Akt inhibitors, siRNA, dominant-negative Akt mutant; Western blot and RT-PCR for MMP-1 and collagen\",\n      \"journal\": \"Journal of Investigative Dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — three independent loss-of-function approaches confirm the finding; single lab\",\n      \"pmids\": [\"18323784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MMP1 and ADAMTS1 in tumor cells proteolytically release membrane-bound EGF-like ligands (AREG, HB-EGF, TGFα), which act on osteoblasts via EGFR to suppress OPG expression and potentiate osteoclast differentiation, driving osteolytic bone metastasis. EGFR inhibitors block this cascade.\",\n      \"method\": \"In vitro proteolytic release assays, osteoblast co-culture, EGFR inhibitor treatment, in vivo bone metastasis model, gain/loss-of-function in breast cancer cells\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteolytic assay, in vitro signaling, in vivo model, pharmacological inhibition); highly cited, mechanistically detailed\",\n      \"pmids\": [\"19608765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Akt inhibition upregulates MMP-1 through a CCN2-dependent pathway in human dermal fibroblasts. Akt blockade induces CCN2 expression; CCN2 in turn activates ERK1/2 and Ets1 phosphorylation; ERK1/2 inhibition completely abolishes the CCN2-induced MMP-1 upregulation, establishing a CCN2/ERK1/2/Ets1 → MMP-1 axis.\",\n      \"method\": \"siRNA knockdown of CCN2, CCN2 overexpression, ERK1/2 inhibitor (UO126), Western blot for phospho-ERK1/2 and phospho-Ets1, co-IP\",\n      \"journal\": \"Experimental Dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CCN2 siRNA rescue, pharmacological inhibitor, phosphorylation analysis; single lab with orthogonal methods\",\n      \"pmids\": [\"20201953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MMP1 mRNA abundance is bimodally distributed in HUVECs, linked to a promoter polymorphism. ChIP experiments showed that transcription factors ETS1, ETS2, and GATA3 bind to the MMP1 promoter in the region of this polymorphism, contributing to bimodal expression and differential response to inflammatory mediators.\",\n      \"method\": \"Hierarchical clustering of microarray data, RT-PCR, MMP1 activity assays, DNA sequencing of 69 individuals, chromatin immunoprecipitation (ChIP) for ETS1, ETS2, GATA3\",\n      \"journal\": \"BMC Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP directly identifies TF binding at polymorphic promoter region with functional correlation; single lab\",\n      \"pmids\": [\"21244711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ERK/MAPK pathway mediates EGFR ligand (EGF, TGFα)-induced MMP1 expression in SK-BR3 breast cancer cells. Specific MEK inhibitor U0126 blocks ERK1/2 activation and MMP1 induction; HER family tyrosine kinase inhibitors (erlotinib, lapatinib, canertinib) suppress MMP1. Akt pathway inhibition paradoxically augments MMP1 via reciprocal ERK activation.\",\n      \"method\": \"Western blot, RT-PCR, ELISA, EMSA for AP-1 binding; MEK inhibitor U0126, PI3K inhibitor LY294002, HER TKIs\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibitors with multiple pathway readouts; single lab\",\n      \"pmids\": [\"21440529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Cdc42 inhibits ERK-mediated MMP-1 expression in collagen-activated human keratinocytes. α2β1 integrin contact with type I collagen activates ERK and p38, but not JNK; ERK inhibition blocks collagen-stimulated MMP-1 expression; p38 and JNK inhibition have no effect. Cdc42 suppresses MMP-1 by attenuating ERK activity in this context.\",\n      \"method\": \"siRNA knockdown of Cdc42 in primary human keratinocytes, pharmacological inhibitors of ERK, p38, JNK, Western blot, RT-PCR on collagen-stimulated cells\",\n      \"journal\": \"Journal of Investigative Dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA plus pharmacological inhibitors in primary human keratinocytes on type I collagen substrate; single lab\",\n      \"pmids\": [\"24352036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Lapatinib suppresses MMP1 expression through EGFR and HER2 downstream ERK and AKT signaling pathways in endometrial cancer. The AP-1 binding site in the MMP1 promoter is required for transcriptional activation; forced expression of active ERK or active AKT mutants rescues MMP1 from lapatinib suppression. Both c-fos and c-Jun bound to the AP-1 site must be suppressed for effective MMP1 inhibition.\",\n      \"method\": \"Luciferase reporter assay with MMP1 promoter deletion constructs, active ERK/AKT mutant rescue experiments, Western blot, RT-PCR\",\n      \"journal\": \"Journal of Molecular Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter reporter assay with rescue experiments; single lab with orthogonal approaches\",\n      \"pmids\": [\"24820961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Drosophila Mmp1 and Mmp2 cooperatively drive fat body cell dissociation during metamorphosis with distinct substrate preferences: Mmp1 preferentially cleaves DE-cadherin-mediated cell-cell junctions, while Mmp2 preferentially degrades basement membrane components to destroy cell-BM junctions.\",\n      \"method\": \"Fat body-specific RNAi screen, cellular/biochemical/molecular/genetic epistasis experiments, substrate-specific cleavage assays in Drosophila\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNAi with genetic interaction experiments and biochemical substrate analysis; Drosophila ortholog\",\n      \"pmids\": [\"25520167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-526b directly targets the 377-383 region of the MMP1 3' UTR to suppress MMP1 mRNA expression. Luciferase reporter assays with wild-type and mutant MMP1 3' UTR constructs confirmed this specific binding site.\",\n      \"method\": \"Luciferase reporter assay with 3' UTR constructs and mutants, miR-526b overexpression, RT-PCR in dermal fibroblasts\",\n      \"journal\": \"Experimental & Molecular Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay with mutagenesis validates specific binding site; single lab\",\n      \"pmids\": [\"26292968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Kynurenine upregulates MMP-1 expression via aryl hydrocarbon receptor (AHR) activation in dermal fibroblasts. Specific AHR antagonist (6,2',4'-trimethoxyflavone) inhibited Kyn-dependent modulation of MMP-1 as well as its target gene CYP1A-1, establishing AHR as the upstream receptor mediating this effect.\",\n      \"method\": \"AHR antagonist treatment, AHR nuclear translocation assay, CYP1A-1 expression as AHR target gene reporter, MMP-1 protein/mRNA measurement, in vivo rat fibrosis model\",\n      \"journal\": \"Journal of Cellular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological AHR inhibition with downstream functional readouts in vitro and in vivo; single lab\",\n      \"pmids\": [\"26992058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In rheumatoid arthritis fibroblast-like synoviocytes (FLS), collagen II activates DDR2 which induces CYR61 through AP-1 transcription factor; CYR61 in turn accelerates MMP1 production via ETS1. CYR61 shRNA blockade in vivo reduced arthritis severity, inflammatory cytokine secretion, and bone erosion in collagen-induced arthritis rats.\",\n      \"method\": \"siRNA knockdown, adenoviral CYR61 shRNA in vivo, ChIP, luciferase reporter, co-IP for DDR2/AP-1 interaction, micro-CT bone analysis\",\n      \"journal\": \"Journal of Bone and Mineral Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including ChIP, reporter assays, siRNA, and in vivo model establish the DDR2-AP-1-CYR61-ETS1-MMP1 pathway\",\n      \"pmids\": [\"27653023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MMP1 mRNA-carrying extracellular vesicles from highly metastatic ovarian cancer cells induce MMP1 expression in mesothelial cells, causing apoptosis and destruction of the peritoneal mesothelium barrier. Intact MMP1 mRNAs are selectively packaged in EVs from highly metastatic cells.\",\n      \"method\": \"EV isolation and characterization, whole transcriptome analysis, in vitro mesothelial cell co-culture with EVs, in vivo peritoneal dissemination model, patient ascites EVs\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro and in vivo experiments with patient sample validation; highly cited\",\n      \"pmids\": [\"28262727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Slug (SNAI2) directly binds to three binding sites in the MMP1 promoter to activate MMP1 transcription in multi-drug resistant breast cancer cells. Forced Slug expression in MCF-7 cells upregulates MMP1; Slug knockdown in MCF-7/ADR cells reduces MMP1 expression.\",\n      \"method\": \"Dual luciferase assay with MMP1 promoter, ChIP-qPCR, Slug overexpression and knockdown, Western blot, immunofluorescence\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-qPCR and luciferase reporter directly show Slug binding at MMP1 promoter; single lab with orthogonal methods\",\n      \"pmids\": [\"28334049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Capicua (CIC) transcriptional repressor suppresses MMP1 expression in HCC through repression of ETV4 (a PEA3 group transcription factor). CIC loss leads to ETV4 upregulation, which induces MMP1. MMP1 knockdown completely blocks CIC deficiency-induced HCC cell proliferation and invasion, placing MMP1 as the critical downstream effector of the CIC-ETV4 axis.\",\n      \"method\": \"CIC overexpression and knockdown (in vitro and in vivo), ETV4 expression analysis, MMP1 siRNA rescue experiment, luciferase reporter assays, xenograft mouse model\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis experiment with MMP1 knockdown rescuing the CIC-loss phenotype; in vivo validation; multiple orthogonal methods\",\n      \"pmids\": [\"29251790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GSDMC (Gasdermin C) is induced by UV radiation in human keratinocytes and contributes to MMP-1 expression via activation of ERK and JNK pathways. GSDMC knockdown reduces UV-induced MMP-1 expression; ERK or JNK inhibition suppresses GSDMC-induced MMP-1 expression, placing GSDMC upstream of ERK/JNK in this pathway.\",\n      \"method\": \"GSDMC knockdown and overexpression in primary keratinocytes and HaCaT cells, ERK/JNK pharmacological inhibitors, qRT-PCR, Western blot\",\n      \"journal\": \"Journal of Dermatological Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knockdown and overexpression with pharmacological inhibitor confirmation; single lab\",\n      \"pmids\": [\"29428815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FICZ (an endogenous AHR ligand and tryptophan photo-product) upregulates MMP1 in dermal fibroblasts via an AHR/MEK/ERK signaling pathway. AHR knockdown abolishes FICZ-induced MMP1 upregulation; MEK/ERK inhibitors block the effect; FICZ-induced ERK phosphorylation is AHR-dependent.\",\n      \"method\": \"AHR knockdown, MEK/ERK inhibitors, ERK phosphorylation by Western blot, ELISA and qRT-PCR for MMP1; comparison to UVB-induced MMP1\",\n      \"journal\": \"Journal of Dermatological Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — AHR knockdown and pharmacological inhibitors establish pathway; single lab\",\n      \"pmids\": [\"29703420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"hsa-miR-623 directly binds to the 3' UTR of MMP1 mRNA as confirmed by EMSA, suppresses MMP1 at both mRNA and protein levels, and attenuates IL-8-induced MMP1 expression and subsequent ERK phosphorylation, inhibiting pancreatic cancer cell migration, invasion, and metastasis.\",\n      \"method\": \"In silico analysis, luciferase reporter assay, RNA EMSA, miR-623 mimic transfection, in vitro migration/invasion assays, xenograft mouse model\",\n      \"journal\": \"International Journal of Oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA and luciferase reporter with mutagenesis confirm direct miRNA-MMP1 3'UTR interaction; single lab with in vivo validation\",\n      \"pmids\": [\"31115512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ETV4 transcription factor directly and transcriptionally upregulates MMP1 in non-small cell lung cancer. Luciferase reporter assays show ETV4 directly regulates MMP1 expression; MMP1 inhibition partially abolishes ETV4-induced cell migration, establishing ETV4 as an upstream activator of MMP1 in NSCLC.\",\n      \"method\": \"Microarray analysis, luciferase reporter assay, gain/loss-of-function experiments, in vitro and in vivo tumor models\",\n      \"journal\": \"Molecular Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase reporter demonstrates direct regulation; rescue experiment confirms functional dependence; single lab\",\n      \"pmids\": [\"31670855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Platelet-secreted CCL3 binding to CCR5 on anaplastic thyroid carcinoma cells induces MMP-1 upregulation via NF-κB pathway, promoting tumor cell invasion and migration.\",\n      \"method\": \"CCL3/CCR5 interaction analysis, NF-κB pathway inhibition, MMP-1 expression assay, in vitro invasion/migration assays\",\n      \"journal\": \"Cellular Signalling\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, pharmacological inhibitor of NF-κB without direct promoter evidence\",\n      \"pmids\": [\"31344439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The lncRNA TCONS_00012883 promotes MMP1 expression in colorectal cancer through interaction with DDX3, with YY1 serving as a bridge between the lncRNA, DDX3, and the MMP1 promoter. RNA pulldown identified DDX3 as the protein partner of the lncRNA; ChIP confirmed YY1 binding at the MMP1 promoter.\",\n      \"method\": \"RNA pulldown with mass spectrometry, RIP assay, co-IP, RNA-sequencing, ChIP, rescue experiments\",\n      \"journal\": \"Clinical and Translational Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including mass spectrometry, RIP, co-IP, and ChIP; single lab\",\n      \"pmids\": [\"33135346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EGR-1 transcription factor directly binds to the EGR-1-binding sequence (EBS) in the proximal MMP1 promoter and transactivates MMP1 gene expression in response to TNFα in HaCaT keratinocytes. Mutation of the EBS abolishes EGR-1-mediated promoter activation; EGR-1 silencing reduces TNFα-induced MMP-1 expression. All three MAPKs (ERK1/2, JNK, p38) mediate TNFα-induced MMP-1 via EGR-1 upregulation.\",\n      \"method\": \"Promoter deletion analysis with luciferase reporter, EBS mutation, EGR-1 siRNA knockdown, MAPK inhibitors, ChIP\",\n      \"journal\": \"BMB Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter mutagenesis and ChIP confirm direct EGR-1 binding; MAPK inhibitors placed upstream; single lab\",\n      \"pmids\": [\"32317080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MMP1 expression by large cell carcinoma (LCC) cells induces premature senescence in tumor-associated fibroblasts (TAFs), which in turn drives LCC cell growth and invasion. MMP1 combined with TGF-β1 is sufficient to induce fibroblast senescence. PAR-1 and oxidative stress are implicated in MMP1/TGF-β1-induced TAF senescence.\",\n      \"method\": \"MMP1 siRNA knockdown in LCC cell lines, co-culture with pulmonary fibroblasts, mouse xenograft models, recombinant MMP1 + TGF-β1 treatment, PAR-1 inhibition, oxidative stress markers\",\n      \"journal\": \"Cancer Letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function combined with rescue using recombinant MMP1, in vitro and in vivo validation, PAR-1 implicated as receptor; multiple orthogonal approaches\",\n      \"pmids\": [\"33684534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"circDLC1 suppresses MMP1 expression in hepatocellular carcinoma by binding to RNA-binding protein HuR, reducing the interaction between HuR and MMP1 mRNA, thereby destabilizing MMP1 mRNA. RIP assays and biotin-labeled RNA pulldown confirmed the circDLC1-HuR interaction.\",\n      \"method\": \"RNA FISH, RIP assay, biotin-labeled RNA pulldown, RNA-seq, overexpression and silencing of circDLC1 in vitro and in vivo\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP and pulldown validate circRNA-protein interaction; mechanistic link to MMP1 mRNA stability established; single lab with in vivo validation\",\n      \"pmids\": [\"33391541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Tumor-associated macrophage (TAM)-derived MMP1 promotes colon cancer cell proliferation via PAR-1 receptor signaling through MAPK/ERK activation, which upregulates c-Myc and ETV4. ETV4 in turn binds the MMP1 promoter and activates MMP1 transcription, creating a positive MMP1/PAR-1/ERK/ETV4/MMP1 feedback loop. Exogenous MMP1 activates cdc25a/CDK4-cyclin D1 and p21/cdc2-cyclin B1 complexes.\",\n      \"method\": \"PAR-1 inhibition, MAPK/ERK inhibition, ETV4 ChIP at MMP1 promoter, cell cycle analysis, co-culture of TAMs with cancer cells, in vitro and in vivo experiments\",\n      \"journal\": \"Cell Death Discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms ETV4 binding at MMP1 promoter; PAR-1 and ERK inhibition establish pathway; single lab with multiple methods\",\n      \"pmids\": [\"34753916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Transformed MDCK cells with oncogenic H-Ras overexpress MMP1, and MMP1 is necessary for cell migration, invasion, anchorage-independent growth, and tumor formation. MMP1 proteolytically cleaves laminin subunit alpha-5 (LAMA5), generating fragments that promote endothelial cell angiogenesis via integrin αvβ3, representing a VEGF-independent mechanism for tumor-promoted angiogenesis.\",\n      \"method\": \"MMP1 knockdown (siRNA), in vivo xenograft model, secretome analysis by MS, antibody-based integrin αvβ3 inhibition, endothelial tube formation assay\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel MMP1 substrate (LAMA5) identified via secretome MS; integrin inhibition confirms functional mechanism; single lab with in vitro and in vivo data\",\n      \"pmids\": [\"27324842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RUNX2 directly binds to specific motifs in the MMP1 promoter and activates MMP1 transcription in triple negative breast cancer, promoting proliferation, migration, invasion, and chemoresistance. ChIP confirmed RUNX2 occupancy at the MMP1 promoter.\",\n      \"method\": \"ChIP assay, qRT-PCR, RNA sequencing, RUNX2 siRNA knockdown, in vivo tumorigenicity test, bioinformatic correlation analysis\",\n      \"journal\": \"Frontiers in Oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP directly confirms transcription factor binding at MMP1 promoter; knockdown with in vivo validation; single lab\",\n      \"pmids\": [\"36483054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NAT10 (N-acetyltransferase 10) promotes MMP1 mRNA stability through N4-acetylcytidine (ac4C) RNA acetylation of MMP1 mRNA in oral squamous cell carcinoma. NAT10 knockdown reduces both total and ac4C-acetylated MMP1 mRNA levels and decreases mRNA stability, impairing tumor growth and metastasis in an MMP1-dependent manner.\",\n      \"method\": \"NAT10 knockdown (lentiviral), ac4C-RIP assay, mRNA stability assay, xenograft experiments, rescue experiments with MMP1 overexpression\",\n      \"journal\": \"Cancer Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ac4C-RIP directly demonstrates RNA acetylation of MMP1 mRNA; mRNA stability assay confirms mechanism; in vivo validation; single lab\",\n      \"pmids\": [\"37705232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"IL-8 activates STAT3 signaling in fibroblasts, which elevates MMP1 expression to promote degradation of extracellular matrix and enhance invasion of head and neck squamous cell carcinoma cells. STAT3 phosphorylation inhibitor (TPCA-1) impairs fibroblast-induced HNSCC invasion.\",\n      \"method\": \"STAT3 inhibitor (TPCA-1), MMP1 expression analysis, in vitro invasion assay with fibroblast-cancer cell co-culture\",\n      \"journal\": \"Cell Death Discovery\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — pharmacological inhibitor study without direct STAT3-MMP1 promoter binding evidence; single method\",\n      \"pmids\": [\"38320998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MMP1 upregulation through promoter hypomethylation drives tamoxifen resistance in breast cancer. MMP1 knockdown via shRNA increases tamoxifen sensitivity and apoptosis in resistant MCF-7 cells; xenograft experiments confirm retarded tumor growth with MMP1 suppression under tamoxifen treatment. Methylation level is inversely associated with MMP1 expression.\",\n      \"method\": \"Methylation microarray, quantitative RT-PCR, Western blot, IHC, colony formation assay, flow cytometry for apoptosis, xenograft mouse model with MMP1 shRNA\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epigenetic mechanism (promoter hypomethylation) correlated with expression and functional phenotype; in vivo validation; single lab\",\n      \"pmids\": [\"35267540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"IL-1β-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts is mediated through the p38/JNK/AP-1 signaling pathway. Cordycepin inhibits this by blocking p38/JNK and AP-1 activation, but not ERK or NF-κB activation.\",\n      \"method\": \"Western blot for MAPK phosphorylation, EMSA for NF-κB and AP-1 binding, ELISA, RT-PCR, primary RA synovial fibroblasts\",\n      \"journal\": \"Rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA directly measures AP-1 binding; multiple pathway readouts; single lab with primary patient cells\",\n      \"pmids\": [\"19056796\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MMP-1 is a secreted zinc-dependent collagenase whose transcription is activated downstream of multiple upstream pathways (ERK/MAPK, JNK, AP-1, STAT3, ETS factors such as ETS1/ETV4, and transcription factors EGR-1, RUNX2, and Slug binding its promoter), whose mRNA stability is regulated by RNA-binding protein HuR and ac4C acetylation (NAT10), and whose activity is directed toward fibrillar type I collagen through a substrate specificity domain encoded by exon 5; at the cell surface, active MMP-1 can signal through PAR-1 to drive ERK/ETV4 positive feedback, while its extracellular substrates include EGF-like ligands (to drive osteoclastogenesis via EGFR on osteoblasts), laminin-α5 (to promote angiogenesis via integrin αvβ3), and DE-cadherin (to enable tissue remodeling), collectively driving invasion, metastasis, ECM degradation, fibroblast senescence, and drug resistance in cancer and inflammatory disease contexts.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1986,\n      \"finding\": \"MMP1 (human fibroblast collagenase) is synthesized as a preproenzyme (Mr 54,092) with a 19-amino-acid signal peptide; proteolytic activation removes 81 amino-terminal residues, yielding the active enzyme; the sequence is homologous to an oncogene-induced rat protein.\",\n      \"method\": \"cDNA cloning and sequence analysis of human skin collagenase mRNA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — primary sequence determination by cDNA cloning, foundational paper with 663 citations\",\n      \"pmids\": [\"3009463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"The MMP1 (collagenase) gene contains a 32-bp 5'-flanking element (positions −73 to −42) that functions as a phorbol-ester (TPA)-inducible enhancer, acting in a position- and orientation-independent manner to drive transcription.\",\n      \"method\": \"5' and 3' deletion mutagenesis of the MMP1 promoter region followed by transfection into human/murine cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct mutagenesis with functional readout; foundational paper with 745 citations\",\n      \"pmids\": [\"3037355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The crystal structure of the MMP1 catalytic domain complexed with an inhibitor at 2.4 Å resolution revealed a catalytic zinc ion, a second structural zinc ion, and a calcium ion critical for tertiary structure stability; the fold is homologous to thermolysin and astacin despite low sequence homology.\",\n      \"method\": \"X-ray crystallography of inhibitor-bound MMP1 catalytic domain\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional inhibitor complex; 278 citations\",\n      \"pmids\": [\"8278810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"MMP1 (along with MMP-3) degrades insulin-like growth factor-binding protein-3 (IGFBP-3) in vitro, cleaving within the mid-region of the binding protein, suggesting a role for MMP1 in modulating IGF bioavailability.\",\n      \"method\": \"Immunoaffinity depletion of MMPs from conditioned medium, in vitro cleavage assays with purified recombinant enzymes, and N-terminal sequencing of cleavage products\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro cleavage with sequencing of cleavage sites; 269 citations\",\n      \"pmids\": [\"7523391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Human skin mast cell chymase directly activates interstitial procollagenase (pro-MMP1) by cleaving the Leu83–Thr84 bond in a single step, without intermediate species; heparin accelerates this activation and prevents further degradation of active MMP1.\",\n      \"method\": \"In vitro activation assays with purified human chymase and procollagenase, N-terminal sequencing of activation products, time- and concentration-dependence measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted biochemical activation with precise cleavage-site sequencing; 260 citations\",\n      \"pmids\": [\"8027075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"MMP-7 (matrilysin) activates pro-MMP1 by cleaving the Gln80–Phe81 bond, an activity enhanced ~6.5-fold in the presence of APMA, revealing a cascade activation mechanism among MMPs.\",\n      \"method\": \"In vitro activation assays with purified MMP-7 and pro-MMP1, N-terminal sequencing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted biochemical assay with cleavage-site identification; 257 citations\",\n      \"pmids\": [\"7896811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MMP1 is a zinc-dependent endopeptidase and the most ubiquitously expressed interstitial collagenase; it is the primary enzyme responsible for initial cleavage of fibrillar collagens (especially types I, II, III) within the extracellular matrix. Its activity is controlled transcriptionally, by zymogen activation, and by TIMPs.\",\n      \"method\": \"Comprehensive review/biochemical characterization collating structural, enzymatic, and inhibitor data\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational review synthesizing extensive biochemical data; 3561 citations\",\n      \"pmids\": [\"10419448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MMP1, MMP-13, and other collagenases (but not MMP-7, MMP-8, or MMP-9) cleave monocyte chemoattractant protein-3 (MCP-3) between residues 4 and 5, generating antagonists of CC chemokine receptors CCR-1, -2, and -3 that inhibit chemotaxis and reduce inflammation in vivo.\",\n      \"method\": \"In vitro cleavage of recombinant chemokines by 8 recombinant MMPs, receptor-binding assays, transwell migration assays, in vivo carrageenan paw-edema model\",\n      \"journal\": \"Science / Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted cleavage assay with multiple MMPs, in vitro receptor assays, and in vivo validation; replicated across two papers\",\n      \"pmids\": [\"10947989\", \"12149192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The region of MMP1 encoded by exon 5 determines substrate specificity (collagenolytic activity) and inhibitor selectivity: a chimeric enzyme with MMP-3's exon-5 region substituted for MMP-1's retained only ~2.2% of wild-type collagenolytic activity against type I collagen and displayed MMP-3-like kinetics on synthetic substrates and with TIMP-2.\",\n      \"method\": \"Chimeric enzyme construction (exon-5 swap between MMP-1 and MMP-3), in vitro collagen cleavage assays, synthetic substrate kinetics, TIMP inhibition assays\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis/chimera with multiple in vitro functional readouts\",\n      \"pmids\": [\"11248710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MMP-1 functions as a protease agonist of PAR1 (protease-activated receptor-1): MMP-1 derived from stromal fibroblasts cleaves PAR1 at the correct site to generate PAR1-dependent Ca2+ signals and promotes breast carcinoma cell migration and invasion in a xenograft model.\",\n      \"method\": \"Xenograft tumor model, PAR1 expression/knockdown, Ca2+ signaling assays, migration assays, MMP-1 activity assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — receptor cleavage confirmed with signaling readout and in vivo xenograft; 664 citations\",\n      \"pmids\": [\"15707890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In Drosophila, JNK signaling resulting from loss of the polarity gene scribble promotes tumor cell invasiveness through Fos-dependent transcriptional activation of mmp1 downstream of JNK; TIMP expression or Mmp1 RNAi knockdown suppresses invasion, placing Mmp1 as the effector of JNK-driven invasion in a Ras-cooperative tumor context.\",\n      \"method\": \"Genetic epistasis in Drosophila imaginal disc clones: RNAi knockdown of mmp1, TIMP overexpression, loss-of-function/gain-of-function of JNK/Ras pathway components, invasion assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic epistasis with multiple loss-of-function approaches and defined invasion phenotype; 332 citations\",\n      \"pmids\": [\"17082773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MMP1 and MMP-2 together facilitate the release of circulating tumor cells into the bloodstream and their extravasation into the lung to seed pulmonary metastasis; MMP1 (expressed in human breast cancer cells) is required for tumor blood-vessel assembly and breaching of lung capillaries.\",\n      \"method\": \"Genetic knockdown and pharmacological inhibition of MMP1/MMP2 in breast cancer xenograft and lung metastasis models; angiogenesis assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic/pharmacological loss-of-function with specific in vivo metastatic phenotype; 554 citations\",\n      \"pmids\": [\"17429393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UV-induced DNA damage in epidermal keratinocytes is a primary trigger for MMP-1 induction in both the epidermis and dermis: photolyase-mediated repair of UV-induced DNA lesions in keratinocytes reduced MMP-1 mRNA and protein in skin, and conditioned medium from UV-irradiated keratinocytes induced MMP-1 in unirradiated fibroblasts through soluble mediators; DNA-repair enzyme pretreatment of keratinocytes blocked this paracrine MMP-1 induction.\",\n      \"method\": \"Liposome-encapsulated DNA repair enzymes applied to human skin ex vivo; conditioned medium transfer experiments between irradiated keratinocytes and unirradiated fibroblasts; MMP-1 mRNA/protein measurement\",\n      \"journal\": \"Experimental dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection using DNA repair enzymes and conditioned medium transfer with defined molecular readouts\",\n      \"pmids\": [\"18459971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Met receptor tyrosine kinase phosphorylates MUC1 cytoplasmic tail at the YHPM tyrosine; phosphorylated MUC1CT translocates to the nucleus, enhances its interaction with p53, which suppresses AP-1 transcription factor activity at the MMP1 promoter, thereby reducing MMP1 transcription and HGF-induced cancer cell invasiveness.\",\n      \"method\": \"Co-IP, real-time confocal imaging of nuclear MUC1CT localization, kinase assays, AP-1 reporter assays, promoter-interaction studies, invasion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — phosphorylation site identified, nuclear localization directly imaged, promoter occupancy linked to MMP1 expression and invasion\",\n      \"pmids\": [\"18625714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Akt blockade in human dermal fibroblasts upregulates MMP1 production and reverses TGF-β-mediated MMP1 suppression, while simultaneously reducing type I collagen; this dual profibrotic role of Akt (increasing collagen and decreasing MMP1-mediated degradation) is exacerbated in systemic sclerosis fibroblasts.\",\n      \"method\": \"Pharmacological Akt inhibitors, siRNA knockdown, dominant-negative Akt mutant; Western blot for collagen and MMP1; SSc fibroblast comparison\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple independent inhibition strategies (pharmacological + siRNA + dominant-negative) with consistent MMP1 phenotype\",\n      \"pmids\": [\"18323784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ADAMTS1 and MMP1, expressed by tumor cells, orchestrate a paracrine signaling cascade in bone metastasis: both metalloproteinases proteolytically release membrane-bound EGF-like ligands (AREG, HB-EGF, TGFα) from tumor cells, which then suppress osteoprotegerin (OPG) in osteoblasts via EGFR, thereby potentiating osteoclast differentiation and osteolytic bone metastasis.\",\n      \"method\": \"In vitro and in vivo bone metastasis models, siRNA knockdown of MMP1/ADAMTS1, EGFR inhibitors, EGF-like ligand release assays, osteoclast differentiation assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological loss-of-function with mechanistic dissection of substrate release and downstream signaling; 247 citations\",\n      \"pmids\": [\"19608765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cdc42 downregulates MMP-1 expression in human skin fibroblasts by suppressing the ERK1/2 pathway: Cdc42 siRNA silencing caused a 15-fold increase in MMP-1 secretion that was dependent on ERK1/2 (but not p38 or RhoA-ROCK), and was partially reduced by co-silencing Rac1, placing Cdc42 upstream of Rac1 and ERK1/2 in the regulation of MMP-1.\",\n      \"method\": \"siRNA silencing of Cdc42, RhoA, and Rac1; rescue with wild-type Cdc42; chemical kinase inhibitors; ERK1/2 and p38 phosphorylation assays; MMP-1 mRNA and secretion measurement\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple siRNAs + siRNA rescue + chemical inhibitors establishing epistatic pathway; 57 citations\",\n      \"pmids\": [\"15728253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"EPA inhibits UV-induced MMP-1 expression in human dermal fibroblasts by blocking activation of MEK1/ERK and SEK1/JNK kinases, thereby reducing c-Fos expression and c-Jun phosphorylation and suppressing AP-1 DNA binding activity; this effect is independent of antioxidant activity.\",\n      \"method\": \"In vitro UV irradiation of fibroblasts with EPA pretreatment; kinase inhibitors; AP-1 EMSA; c-Fos/c-Jun Western blots; MMP-1 mRNA/protein measurement\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pathway dissection using multiple pharmacological inhibitors combined with transcription factor binding assays\",\n      \"pmids\": [\"15930517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IL-17 induces MMP-1 expression in primary human cardiac fibroblasts through p38 MAPK- and ERK1/2-dependent activation of AP-1 (c-Fos, c-Jun, Fra-1), NF-κB (p50/p65), and C/EBP-β; inhibiting any of these transcription factors attenuates MMP-1 expression.\",\n      \"method\": \"siRNA knockdown, antisense oligonucleotides, dominant-negative expression vectors, pharmacological kinase inhibitors (SB-203580, PD-98059), EMSA, reporter assays, Northern blot, ELISA\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal loss-of-function approaches delineating AP-1/NF-κB/C-EBP pathway upstream of MMP-1; 214 citations\",\n      \"pmids\": [\"17921324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Akt inhibition upregulates MMP1 in human dermal fibroblasts through a CCN2 (CTGF)-dependent pathway: Akt blockade induces CCN2 expression, which in turn activates ERK1/2 and Ets1 phosphorylation, leading to MMP1 transcription; ERK1/2 inhibition abolishes CCN2-driven MMP1 induction.\",\n      \"method\": \"Pharmacological Akt inhibitor, Akt siRNA, CCN2 siRNA, ERK1/2 inhibitor (UO126), Western blotting for phospho-ERK1/2 and phospho-Ets1, MMP1 protein/mRNA measurement\",\n      \"journal\": \"Experimental dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent Akt inhibition methods combined with CCN2 siRNA rescue and kinase pathway dissection\",\n      \"pmids\": [\"20201953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MMP1 promoter polymorphism (identified by ChIP) creates binding sites for transcription factors ETS1, ETS2, and GATA3; the allelic variant that accommodates these transcription factor binding events drives bimodal MMP1 mRNA expression across individuals in endothelial cells both at baseline and in response to inflammatory mediators.\",\n      \"method\": \"Hierarchical clustering of microarray data from 15 HUVEC individuals, RT-PCR validation, MMP1 activity assays, DNA sequencing of 69 individuals, chromatin immunoprecipitation (ChIP) for ETS1/ETS2/GATA3\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP identifies transcription factor binding, but single-lab study with population-level functional inference\",\n      \"pmids\": [\"21244711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Cdc42 negatively regulates MMP-1 expression in collagen-activated human keratinocytes by suppressing ERK activity; contact with type I collagen via α2β1 integrin activates ERK (but not JNK or p38), and ERK inhibition blocks collagen-stimulated MMP-1 expression and keratinocyte migration on collagen.\",\n      \"method\": \"ERK, p38, and JNK pharmacological inhibitors; Cdc42 activity analysis; MMP-1 mRNA/protein in primary neonatal and adult keratinocytes stimulated with type I collagen\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — integrin→ERK→MMP-1→migration axis established with orthogonal inhibitors in primary cells\",\n      \"pmids\": [\"24352036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Fluid shear stress above a threshold (~10 dyn/cm²) triggers endothelial cell sprouting (angiogenesis) through upregulation of MMP1; siRNA-mediated MMP1 knockdown abrogates flow-induced sprouting, establishing MMP1 as a required downstream effector of shear-stress-driven angiogenesis.\",\n      \"method\": \"Microfluidic shear stress devices, siRNA knockdown of MMP1, sprouting/invasion assays in 3D matrix\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA loss-of-function with defined cellular phenotype in well-controlled microfluidic system; 302 citations\",\n      \"pmids\": [\"24843171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In Drosophila metamorphosis, Mmp1 preferentially cleaves DE-cadherin-mediated cell–cell junctions (while Mmp2 degrades basement membrane), and cooperative action of both MMPs is required for complete fat body tissue dissociation into individual cells.\",\n      \"method\": \"Fat body-specific RNAi screen in Drosophila, biochemical substrate assays, genetic interaction experiments, cellular imaging\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — RNAi screen plus genetic epistasis and substrate characterization; distinct roles of Mmp1 vs Mmp2 established\",\n      \"pmids\": [\"25520167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-203 overexpression in rheumatoid arthritis synovial fibroblasts leads to increased secretion of MMP-1 and IL-6 via the NF-κB pathway; DNA demethylation (5-azaC) increases miR-203 expression, identifying methylation-dependent epigenetic regulation as a mechanism controlling MMP-1 levels in RA fibroblasts.\",\n      \"method\": \"miR-203 precursor transfection in RASFs, NF-κB pathway inhibition (SC-514), real-time PCR, ELISA for MMP-1 and IL-6, 5-azaC treatment\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function miRNA with pathway inhibitor confirming NF-κB link; 262 citations\",\n      \"pmids\": [\"21279994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-526b directly targets the 377–383 region of the MMP1 3' UTR to suppress MMP1 mRNA expression; reporter constructs with mutated 3'UTR abolished this regulation, and miR-526b and MMP1 mRNA show inverse expression between adult dermal and neonatal fibroblasts.\",\n      \"method\": \"3'UTR luciferase reporter assays with wild-type and mutant MMP1 3'UTR, miR-526b overexpression, RT-PCR in dermal/neonatal fibroblasts\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct 3'UTR targeting confirmed by mutagenesis of binding site, single lab\",\n      \"pmids\": [\"26292968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MMP1 secreted by transformed (H-Ras-oncogenic) epithelial cells cleaves laminin subunit alpha-5 (LAMA5), generating proteolytic fragments that promote endothelial cell angiogenesis via integrin αvβ3; MMP1 knockdown reduces tumor invasion, anchorage-independent growth, and xenograft tumor volume, and diminishes the angiogenic potency of the secretome.\",\n      \"method\": \"MMP1 siRNA knockdown in 21D1 cells, in vivo xenograft, secretome transfer to fibroblasts/endothelial cells, angiogenesis assays, integrin αvβ3 antibody inhibition, mass spectrometry identification of LAMA5 as MMP1 substrate\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — novel substrate identified by mass spectrometry, functional validation in vitro and in vivo, integrin pathway confirmed\",\n      \"pmids\": [\"27324842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The DDR2–AP-1–CYR61–ETS1–MMP1 signaling loop in fibroblast-like synoviocytes (FLS) mediates collagen II-induced bone erosion in rheumatoid arthritis: collagen II activates DDR2 phosphorylation → AP-1 → CYR61 expression → ETS1-driven MMP1 production → FLS invasion and migration; adenoviral CYR61 shRNA in vivo reduces arthritis severity and bone erosion.\",\n      \"method\": \"siRNA/shRNA knockdown, adenoviral shRNA in vivo (CIA rat model), micro-CT, AP-1 ChIP, co-IP, FLS invasion/migration assays\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multi-step pathway validated by independent knockdowns and in vivo shRNA model with bone erosion readout\",\n      \"pmids\": [\"27653023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Slug (SNAI2) directly binds three E-box/Slug-binding sites in the MMP1 promoter to enhance MMP1 transcription in breast cancer cells with multi-drug resistance; ChIP-qPCR and dual luciferase assays confirmed direct promoter binding, and MMP1 overexpression reduced drug sensitivity while MMP1 knockdown enhanced sensitivity in MDR cells.\",\n      \"method\": \"Dual luciferase assays with MMP1 promoter constructs, ChIP-qPCR, Slug overexpression/knockdown, MMP1 overexpression/knockdown, drug sensitivity assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding confirmed by ChIP and mutagenesis; functional consequence in drug resistance established\",\n      \"pmids\": [\"28334049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The transcriptional repressor Capicua (CIC) suppresses HCC progression by repressing ETV4 expression; ETV4 in turn directly drives MMP1 expression in HCC cells, and MMP1 knockdown completely blocks the proliferation and invasion phenotype caused by CIC deficiency, establishing a CIC–ETV4–MMP1 regulatory axis.\",\n      \"method\": \"CIC overexpression/knockdown in vitro and in vivo, ETV4 and MMP1 knockdown, proliferation/invasion assays, luciferase reporter assays\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistatic rescue experiment (MMP1 KD completely reverses CIC-KD phenotype) establishes pathway order; 76 citations\",\n      \"pmids\": [\"29251790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FICZ (an endogenous AHR ligand) upregulates MMP1 expression in normal human dermal fibroblasts through AHR-dependent MEK/ERK signaling; AHR knockdown and MEK/ERK inhibitors block FICZ-induced MMP1 upregulation, while JNK/p38 inhibitors are additionally required for UVB-induced MMP1.\",\n      \"method\": \"AHR-knockdown NHDFs, selective MAPK inhibitors, MEK/ERK phosphorylation (Western blot), ELISA, qRT-PCR\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — AHR knockdown plus selective kinase inhibitors distinguishing two upstream induction pathways\",\n      \"pmids\": [\"29703420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Gasdermin C (GSDMC), induced by UV irradiation at late time points, is required for UV-induced MMP-1 expression (but not MMP-3 or MMP-9) in human skin keratinocytes; GSDMC overexpression increases ERK and JNK activation, and inhibition of ERK or JNK suppresses GSDMC-induced MMP-1 expression.\",\n      \"method\": \"GSDMC knockdown and overexpression in HaCaT and primary keratinocytes, ERK/JNK inhibitors, qRT-PCR, Western blot\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss- and gain-of-function with kinase inhibitor pathway dissection; single lab, single study\",\n      \"pmids\": [\"29428815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ETV4 directly activates MMP1 transcription in NSCLC cells; ETV4 overexpression increases MMP1 mRNA and protein, and luciferase reporter assays confirm direct ETV4 regulation of the MMP1 promoter; inhibition of MMP1 partially abolishes ETV4-driven cell proliferation and migration.\",\n      \"method\": \"ETV4 gain/loss-of-function, microarray, luciferase reporter assays, MMP1 knockdown rescue experiments, in vivo xenograft\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter regulation confirmed by luciferase assay; partial rescue by MMP1 inhibition validates functional significance\",\n      \"pmids\": [\"31670855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EGR-1 (early growth response protein 1) directly binds to an EGR-1 binding sequence (EBS) in the proximal MMP1 promoter and transactivates MMP1 in response to TNFα in keratinocytes; EGR-1 silencing reduces TNFα-induced MMP-1 expression, and mutation of the EBS abolishes EGR-1-mediated promoter activation. All three MAPKs (ERK1/2, JNK, p38) mediate TNFα-induced MMP-1 via EGR-1 upregulation.\",\n      \"method\": \"Promoter deletion analysis, luciferase reporter assays, EGR-1 siRNA, EGR-1 overexpression, EBS site-directed mutagenesis, MAPK inhibitors, Western blot\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — promoter mutagenesis combined with siRNA knockdown and overexpression validates direct EGR-1→MMP1 transcriptional activation\",\n      \"pmids\": [\"32317080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MMP1 secreted by LCC tumor cells induces premature senescence in pulmonary fibroblasts (via PAR-1 and oxidative stress), and senescent fibroblasts in turn drive LCC cell growth and invasion; MMP1 knockdown prevents fibroblast senescence and tumor promotion in cell culture and mouse models, and MMP1 combined with TGF-β1 is sufficient to induce fibroblast senescence.\",\n      \"method\": \"MMP1 overexpression/knockdown in LCC cell lines, co-culture senescence assays, in vivo mouse models, PAR-1 inhibition, oxidative stress assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain/loss-of-function with defined senescence phenotype, PAR-1 mechanism, and in vivo validation\",\n      \"pmids\": [\"33684534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TAM-derived MMP1 activates PAR-1 on colon cancer cells to trigger MAPK/Erk signaling, accelerating cell cycle progression (G0/G1 to S and G2/M) and activating cdc25a/CDK4-cyclin D1 and p21/cdc2-cyclin B1 complexes via c-Myc and ETV4; ETV4 in turn binds the MMP1 promoter to form a positive feedback loop (MMP1/PAR1/Erk1/2/ETV4/MMP1).\",\n      \"method\": \"Exogenous MMP1 treatment, PAR-1 inhibition, MEK/ERK inhibitors, cell cycle analysis, co-IP, ChIP for ETV4 at MMP1 promoter, in vitro/in vivo experiments\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — PAR-1 signaling and ChIP confirmed, positive feedback loop established; single lab study\",\n      \"pmids\": [\"34753916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RUNX2 directly binds to specific motifs in the MMP1 promoter and activates MMP1 transcription in triple-negative breast cancer, as confirmed by ChIP and qRT-PCR; RUNX2 silencing suppresses MMP1 expression and reduces proliferation, migration, invasion, chemoresistance, and in vivo tumorigenicity.\",\n      \"method\": \"RUNX2 siRNA knockdown, RNA-sequencing, ChIP assay at MMP1 promoter, qRT-PCR, in vivo xenograft tumorigenicity\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct promoter binding; functional phenotypes consistent; single lab\",\n      \"pmids\": [\"36483054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NAT10 promotes MMP1 mRNA stability through N4-acetylcytidine (ac4C) acetylation of MMP1 mRNA; NAT10 knockdown reduces both total and ac4C-acetylated MMP1 mRNA and decreases MMP1 mRNA stability, impairing OSCC cell proliferation, migration, invasion, and in vivo tumorigenesis in an MMP1-dependent manner.\",\n      \"method\": \"NAT10 knockdown (lentivirus), acRIP (acetylated RNA immunoprecipitation sequencing), MMP1 mRNA stability assays, xenograft experiments, rescue by MMP1 overexpression\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA modification confirmed by acRIP and mRNA stability assay; MMP1-dependent rescue validates functional link; single lab\",\n      \"pmids\": [\"37705232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MMP1 mRNA is selectively packaged into cancer-derived extracellular vesicles (EVs) from highly metastatic ovarian cancer cells; EV transfer delivers intact MMP1 mRNA to mesothelial cells, upregulating MMP1 expression, inducing apoptosis in mesothelial cells, and facilitating destruction of the peritoneal barrier for peritoneal dissemination.\",\n      \"method\": \"Whole transcriptome analysis, EV isolation and characterization, MMP1 mRNA detection in EVs by qRT-PCR, in vitro apoptosis assays, in vivo peritoneal dissemination model, MMP1 mRNA detection in patient ascites EVs\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EV-mediated mRNA delivery confirmed with functional consequence in vitro and in vivo; novel mechanism, single lab study\",\n      \"pmids\": [\"28262727\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MMP1 (interstitial collagenase-1) is a secreted zinc-dependent endoprotease whose proenzyme is activated extracellularly by enzymes including mast cell chymase (cleaving Leu83–Thr84) and MMP-7; its catalytic domain structure, determined by X-ray crystallography, contains a catalytic zinc, a structural zinc, and a calcium ion, with an exon-5-encoded loop that determines collagen substrate specificity and inhibitor selectivity; MMP1 cleaves fibrillar collagens (types I, II, III), IGFBP-3, MCP chemokines (generating CCR antagonists), LAMA5, and the EGF-like ligands AREG/HB-EGF/TGFα (releasing them from tumor cell surfaces to drive osteoclastogenesis); MMP1 cleaves and activates PAR1 on stromal and cancer cells, generating Ca2+ signals that drive cell migration and invasion; its transcription is induced downstream of AP-1 (c-Fos/c-Jun), NF-κB, C/EBP-β, ETS1/2, GATA3, EGR-1, and ETV4 in response to cytokines (IL-1β, TNFα, IL-17), UV-induced DNA damage, EGFR/ERK signaling, and Cdc42 suppression of ERK, and is suppressed by Akt, RUNX2, Slug, miR-203, miR-526b, miR-145, and ac4C RNA modification (via NAT10); MMP1 promotes tumor invasion, metastasis, angiogenesis (through a shear-stress/MMP1/sprouting axis and LAMA5 fragmentation via integrin αvβ3), and induces fibroblast senescence via PAR-1 and oxidative stress to create a tumor-promoting microenvironment.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MMP1 is a secreted zinc-dependent collagenase that degrades fibrillar type I collagen and other extracellular substrates to drive tissue remodeling, invasion, and metastasis. Substrate specificity for collagen over gelatin is encoded by the exon 5 domain, which also determines TIMP-1/TIMP-2 inhibitor selectivity [PMID:11248710]; additional extracellular substrates include EGF-like ligands whose proteolytic release activates EGFR on osteoblasts to promote osteolytic bone metastasis [PMID:19608765], laminin-α5 whose cleavage fragments drive integrin αvβ3-dependent angiogenesis [PMID:27324842], and DE-cadherin at cell–cell junctions [PMID:25520167]. MMP1 transcription is activated through convergent ERK/MAPK and JNK pathways via AP-1 (c-Fos/c-Jun), with direct promoter binding by ETS1, ETV4, EGR-1, RUNX2, and Slug, and is suppressed by Cdc42-mediated ERK attenuation and CIC-dependent ETV4 repression [PMID:15728253, PMID:29251790, PMID:32317080, PMID:36483054, PMID:28334049]; MMP1 mRNA stability is positively regulated by HuR binding and NAT10-mediated ac4C acetylation [PMID:33391541, PMID:37705232]. Secreted MMP1 signals through PAR-1 to activate ERK/ETV4, establishing a positive feedback loop that promotes cancer cell proliferation, fibroblast senescence, and drug resistance [PMID:34753916, PMID:33684534, PMID:35267540].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Resolving what determines MMP1's collagenase specificity: the exon 5-encoded domain was shown to be both necessary and sufficient for type I collagen cleavage selectivity and TIMP inhibitor binding, distinguishing MMP1 from related MMPs.\",\n      \"evidence\": \"Chimeric MMP-1/MMP-3 enzyme with exon 5 replacement, in vitro kinetic assays with synthetic substrates and TIMPs\",\n      \"pmids\": [\"11248710\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural basis for why exon 5 confers collagen specificity\", \"No in vivo validation of chimera phenotype\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing ERK/MAPK and JNK as the central signaling axes controlling MMP1 transcription: Cdc42 was identified as a suppressor of MMP1 through ERK attenuation in fibroblasts, while UV-induced MMP1 was shown to require both ERK and JNK converging on AP-1.\",\n      \"evidence\": \"siRNA knockdown of Cdc42/Rac1 with rescue and pharmacological ERK/JNK inhibitors in human dermal fibroblasts and keratinocytes\",\n      \"pmids\": [\"15728253\", \"15930517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of ERK vs JNK to MMP1 transcription in different cell types not resolved\", \"Direct AP-1 binding at MMP1 promoter not shown in these studies\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic epistasis in Drosophila established Mmp1 as a required downstream effector of JNK/Fos-driven tumor invasion, providing the first in vivo loss-of-function evidence that MMP1 is essential—not merely correlated—for cooperative oncogene-driven invasion.\",\n      \"evidence\": \"Mmp1 RNAi and TIMP overexpression in scribble-mutant/Ras-activated Drosophila imaginal discs\",\n      \"pmids\": [\"17082773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Drosophila ortholog — direct translational relevance to human MMP1 not established\", \"Specific Mmp1 substrates mediating invasion not identified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Multiple upstream regulatory inputs to MMP1 transcription were mapped: MUC1/p53 suppresses MMP1 via AP-1 inhibition; Akt blockade paradoxically upregulates MMP1; and paracrine UV-damage signals from keratinocytes induce MMP1 in fibroblasts.\",\n      \"evidence\": \"ChIP at MMP1 promoter, kinase assays, dominant-negative Akt, conditioned media transfer with DNA repair enzyme intervention\",\n      \"pmids\": [\"18625714\", \"18323784\", \"18459971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of soluble mediators from UV-damaged keratinocytes unknown\", \"Whether p53/MUC1 suppression operates in non-cancer contexts not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"MMP1 was shown to act as an extracellular protease releasing EGF-like ligands from tumor cell membranes, establishing a non-ECM substrate class and a mechanism for osteolytic bone metastasis through EGFR activation on osteoblasts.\",\n      \"evidence\": \"Proteolytic release assays, osteoblast co-culture, EGFR inhibitor treatment, in vivo bone metastasis model in breast cancer\",\n      \"pmids\": [\"19608765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of MMP1 vs ADAMTS1 in EGF-ligand shedding not fully dissected\", \"Whether this mechanism operates in non-breast cancers unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"A CCN2/ERK1/2/ETS1 signaling axis was identified as the mechanism through which Akt inhibition paradoxically upregulates MMP1, resolving the earlier observation that Akt blockade increases MMP1.\",\n      \"evidence\": \"CCN2 siRNA, CCN2 overexpression, ERK inhibitor UO126, phospho-Ets1 Western blot in dermal fibroblasts\",\n      \"pmids\": [\"20201953\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ETS1 binding at MMP1 promoter not shown in this study\", \"Whether CCN2 axis operates in cancer cells not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Drosophila Mmp1 was shown to preferentially cleave DE-cadherin at cell–cell junctions during fat body remodeling, while AP-1 site requirement for MMP1 promoter activation was confirmed by rescue with active ERK/AKT mutants in endometrial cancer.\",\n      \"evidence\": \"Fat body-specific RNAi with substrate cleavage assays; MMP1 promoter deletion/rescue with constitutively active kinases\",\n      \"pmids\": [\"25520167\", \"24820961\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Human MMP1 cleavage of cadherins not directly demonstrated\", \"Relative importance of ERK vs AKT for MMP1 promoter activation varies by cell type\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Two new upstream pathways were connected to MMP1: DDR2/AP-1/CYR61/ETS1 in rheumatoid arthritis synoviocytes, and AHR activation by kynurenine in fibroblasts; simultaneously, MMP1 cleavage of laminin-α5 was shown to generate pro-angiogenic fragments acting through integrin αvβ3.\",\n      \"evidence\": \"ChIP for ETS1 at MMP1 promoter, CYR61 shRNA in vivo RA model; AHR antagonist with CYP1A-1 reporter; secretome MS identifying LAMA5 fragments with integrin blocking antibodies\",\n      \"pmids\": [\"27653023\", \"26992058\", \"27324842\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether AHR binds MMP1 promoter directly or acts through intermediaries not resolved\", \"LAMA5 cleavage site by MMP1 not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The CIC/ETV4/MMP1 transcriptional axis was established as a critical driver of hepatocellular carcinoma: CIC represses ETV4, which directly activates MMP1 transcription, and MMP1 knockdown fully rescues CIC-loss-driven proliferation and invasion.\",\n      \"evidence\": \"CIC overexpression/knockdown, ETV4 reporter assays, MMP1 siRNA epistasis rescue, xenograft model\",\n      \"pmids\": [\"29251790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CIC directly binds ETV4 promoter or acts indirectly not fully resolved\", \"Applicability beyond HCC not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"ETV4 was confirmed as a direct MMP1 transcriptional activator across multiple cancer types (NSCLC, colon), while miR-623 was identified as a direct post-transcriptional suppressor of MMP1 mRNA through 3′ UTR binding.\",\n      \"evidence\": \"Luciferase reporter and ChIP for ETV4 at MMP1 promoter; RNA EMSA confirming miR-623 binding to MMP1 3′ UTR\",\n      \"pmids\": [\"31670855\", \"31115512\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous regulation of miR-623 levels in tumors not characterized\", \"Whether ETV4 and AP-1 cooperate or compete at the MMP1 promoter unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A PAR-1/ERK/ETV4/MMP1 positive feedback loop was delineated: secreted MMP1 activates PAR-1 on target cells, triggering ERK-dependent ETV4 upregulation that in turn transcribes more MMP1; this loop drives fibroblast senescence and cancer cell proliferation.\",\n      \"evidence\": \"PAR-1 inhibition, ERK inhibition, ETV4 ChIP at MMP1 promoter, co-culture of TAMs with colon cancer cells; recombinant MMP1 + TGF-β1 senescence assay with PAR-1 blockade\",\n      \"pmids\": [\"34753916\", \"33684534\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PAR-1 cleavage by MMP1 generates a specific tethered ligand peptide not characterized\", \"Feedback loop not yet validated in non-colon cancer systems\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"MMP1 mRNA stability was shown to be regulated by HuR binding, which is competitively inhibited by the circular RNA circDLC1 in hepatocellular carcinoma, providing a non-transcriptional mechanism for MMP1 control.\",\n      \"evidence\": \"RIP assay, biotin-labeled RNA pulldown for circDLC1-HuR interaction, RNA stability assays\",\n      \"pmids\": [\"33391541\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HuR binds specific AU-rich elements in MMP1 mRNA not mapped\", \"Generalizability of circDLC1-HuR axis beyond HCC not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Additional transcriptional regulators (RUNX2, Slug/SNAI2) and an epigenetic mechanism (promoter hypomethylation) were linked to MMP1 activation in breast cancer, while NAT10-mediated ac4C acetylation of MMP1 mRNA was identified as a novel post-transcriptional stabilization mechanism.\",\n      \"evidence\": \"ChIP for RUNX2 and Slug at MMP1 promoter; methylation microarray with shRNA knockdown and xenograft; ac4C-RIP with mRNA stability assays\",\n      \"pmids\": [\"36483054\", \"28334049\", \"35267540\", \"37705232\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether RUNX2 and Slug cooperate or function in distinct contexts not resolved\", \"ac4C modification sites on MMP1 mRNA not mapped at nucleotide resolution\", \"Interplay between promoter methylation and transcription factor access not characterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis of PAR-1 activation by MMP1 cleavage, whether the PAR-1/ERK/ETV4 feedback loop operates in vivo in patient tumors, and how the multiple transcriptional and post-transcriptional regulatory inputs are integrated in a cell-type-specific manner.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of MMP1-PAR-1 cleavage interaction\", \"Feedback loop not validated in patient-derived systems\", \"Hierarchy among multiple MMP1 promoter transcription factors in native chromatin context unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 7, 13, 30]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 7, 13, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [7, 17, 27, 30]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [0, 30, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 10, 29]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 19, 34]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PAR1\",\n      \"ETV4\",\n      \"ETS1\",\n      \"HuR\",\n      \"NAT10\",\n      \"TIMP1\",\n      \"TIMP2\",\n      \"LAMA5\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"MMP1 (interstitial collagenase) is a secreted zinc-dependent endopeptidase that initiates degradation of fibrillar collagens (types I, II, III) and cleaves additional extracellular substrates including IGFBP-3, MCP chemokines, LAMA5, and EGF-like ligands (AREG, HB-EGF, TGFα), thereby modulating IGF bioavailability, chemokine signaling, angiogenesis, and osteoclastogenesis [PMID:10419448, PMID:7523391, PMID:10947989, PMID:27324842, PMID:19608765]. MMP1 also functions as a protease agonist of PAR1, generating intracellular Ca²⁺ signals that drive tumor cell migration, invasion, and fibroblast senescence in the tumor microenvironment [PMID:15707890, PMID:33684534]. The proenzyme is activated extracellularly by mast cell chymase (Leu83–Thr84 cleavage) and MMP-7 (Gln80–Phe81 cleavage), and its catalytic domain—containing a catalytic zinc, structural zinc, and calcium—uses an exon-5-encoded loop to confer collagen substrate specificity [PMID:8027075, PMID:7896811, PMID:8278810, PMID:11248710]. MMP1 transcription is induced by AP-1 (c-Fos/c-Jun), NF-κB, C/EBP-β, ETS1/2, EGR-1, ETV4, and RUNX2 downstream of cytokines, UV-induced DNA damage, and ERK/JNK signaling, and is post-transcriptionally regulated by miR-526b and NAT10-mediated ac4C mRNA modification [PMID:3037355, PMID:17921324, PMID:32317080, PMID:29251790, PMID:26292968, PMID:37705232].\",\n  \"teleology\": [\n    {\n      \"year\": 1986,\n      \"claim\": \"Cloning and sequence determination of MMP1 established it as a preproenzyme with a signal peptide and an 81-residue propeptide removed during activation, providing the molecular framework for understanding zymogen processing.\",\n      \"evidence\": \"cDNA cloning and full-length sequencing of human skin fibroblast collagenase mRNA\",\n      \"pmids\": [\"3009463\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Activation mechanism (which proteases cleave the propeptide) was not yet identified\", \"Three-dimensional structure unknown\"]\n    },\n    {\n      \"year\": 1986,\n      \"claim\": \"Identification of a TPA-inducible 32-bp enhancer element in the MMP1 promoter revealed that MMP1 is transcriptionally regulated by phorbol ester signaling, founding the study of MMP1 transcriptional control.\",\n      \"evidence\": \"Deletion mutagenesis of the MMP1 5′-flanking region with transfection reporter assays\",\n      \"pmids\": [\"3037355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factors binding this element were not identified\", \"Physiological inducers beyond TPA not yet explored\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Crystal structure determination of the MMP1 catalytic domain revealed the catalytic zinc, structural zinc, and calcium ion, and showed a thermolysin/astacin-like fold, providing the structural basis for inhibitor design and understanding catalytic mechanism.\",\n      \"evidence\": \"X-ray crystallography at 2.4 Å of inhibitor-bound MMP1 catalytic domain\",\n      \"pmids\": [\"8278810\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length structure with hemopexin domain not determined\", \"Structural basis for collagen specificity not resolved at this stage\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identification of mast cell chymase and subsequently MMP-7 as physiological activators of pro-MMP1, with precise cleavage sites mapped, resolved how the zymogen is processed extracellularly and revealed cascade activation among MMPs.\",\n      \"evidence\": \"In vitro activation assays with purified chymase and MMP-7, N-terminal sequencing of cleavage products\",\n      \"pmids\": [\"8027075\", \"7896811\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of each activation pathway in specific tissues not established\", \"Whether other proteases contribute to activation in inflammatory contexts\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstration that MMP1 cleaves IGFBP-3 expanded its substrate repertoire beyond collagens and implicated MMP1 in growth factor bioavailability regulation.\",\n      \"evidence\": \"Reconstituted in vitro cleavage with recombinant enzymes and N-terminal sequencing of cleavage products\",\n      \"pmids\": [\"7523391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance for IGF signaling not confirmed\", \"Other IGFBP family members as substrates not tested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that MMP1 cleaves MCP-3 to generate CC chemokine receptor antagonists revealed an anti-inflammatory function, showing MMP1 shapes immune cell recruitment beyond simple ECM remodeling.\",\n      \"evidence\": \"In vitro cleavage of recombinant chemokines by multiple MMPs, receptor-binding and chemotaxis assays, in vivo paw-edema model\",\n      \"pmids\": [\"10947989\", \"12149192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative importance of MMP1 vs other collagenases for in vivo chemokine processing unclear\", \"Whether MMP1 cleaves other chemokine families not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Exon-5 domain swap experiments established that the exon-5-encoded loop is the structural determinant of MMP1's collagenolytic specificity and TIMP selectivity, answering why MMP1 but not MMP-3 cleaves fibrillar collagens.\",\n      \"evidence\": \"MMP-1/MMP-3 chimeric enzymes tested on type I collagen, synthetic substrates, and TIMPs\",\n      \"pmids\": [\"11248710\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution mechanism of collagen unwinding by the hemopexin domain not resolved\", \"Whether exon-5 alone is sufficient for collagenolytic activity on type II/III collagens not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"MMP1 was identified as a protease agonist of PAR1, establishing a non-ECM signaling function whereby MMP1-mediated PAR1 cleavage triggers Ca²⁺ signals that drive breast carcinoma invasion—a paradigm shift from purely ECM-degrading roles.\",\n      \"evidence\": \"PAR1 cleavage assays, Ca²⁺ signaling, migration assays, and breast cancer xenograft model\",\n      \"pmids\": [\"15707890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise PAR1 cleavage site by MMP1 vs thrombin-mediated activation and downstream signal divergence not fully resolved\", \"Whether PAR1 activation by MMP1 occurs in non-cancer physiological contexts\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Cdc42 was placed as an upstream negative regulator of MMP1 via ERK suppression, establishing that Rho-family GTPases control MMP1 expression through MAPK pathways in fibroblasts and keratinocytes.\",\n      \"evidence\": \"Cdc42 siRNA with rescue, Rac1 co-silencing, MEK/ERK inhibitors in dermal fibroblasts; later confirmed in collagen-stimulated keratinocytes\",\n      \"pmids\": [\"15728253\", \"24352036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Cdc42 targets upstream of ERK not identified\", \"Whether Cdc42-MMP1 axis operates in vivo tissue remodeling unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Drosophila genetic epistasis showed that Mmp1 is the critical JNK/Fos effector of polarity-loss-driven invasion in cooperative tumors, providing in vivo genetic validation of MMP1 as a tumor invasion executor.\",\n      \"evidence\": \"mmp1 RNAi, TIMP overexpression in Drosophila imaginal disc clones with scribble/Ras tumors\",\n      \"pmids\": [\"17082773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mammalian ortholog relevance of this Drosophila JNK-Mmp1 pathway not validated\", \"Mmp1 substrates in Drosophila invasion not identified in this study\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Combined MMP1/MMP2 loss-of-function in breast cancer xenografts demonstrated that MMP1 is required for intravasation, extravasation, and lung metastasis seeding, defining MMP1 as a rate-limiting protease for the metastatic cascade.\",\n      \"evidence\": \"Genetic knockdown and pharmacological inhibition of MMP1/MMP2 in breast cancer xenograft and lung metastasis models\",\n      \"pmids\": [\"17429393\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contributions of MMP1 vs MMP2 to each metastatic step not fully separated\", \"Host-derived vs tumor-derived MMP1 contributions unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapping the transcriptional cascade upstream of MMP1 in cardiac fibroblasts showed that IL-17 induces MMP1 through p38/ERK → AP-1 + NF-κB + C/EBP-β, establishing multi-transcription-factor convergence as the mechanism for cytokine-driven MMP1 induction.\",\n      \"evidence\": \"siRNA, antisense, dominant-negatives, pharmacological kinase inhibitors, EMSA, and reporter assays in primary cardiac fibroblasts\",\n      \"pmids\": [\"17921324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative quantitative contribution of each transcription factor to total MMP1 output not determined\", \"Whether this multi-factor module applies identically in other cell types\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"UV-induced DNA damage in keratinocytes was identified as the primary trigger for paracrine MMP1 induction in the dermis, establishing an epidermis-to-dermis signaling pathway for photoaging-associated collagen degradation.\",\n      \"evidence\": \"DNA repair enzyme (photolyase) application to UV-irradiated keratinocytes, conditioned medium transfer to fibroblasts\",\n      \"pmids\": [\"18459971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the soluble paracrine mediator from keratinocytes not determined\", \"In vivo relevance beyond ex vivo skin models not confirmed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"MMP1 was shown to release membrane-tethered EGF-like ligands (AREG, HB-EGF, TGFα) from tumor cell surfaces, activating osteoblast EGFR to suppress OPG and drive osteolytic bone metastasis—establishing MMP1 as a sheddase with paracrine signaling consequences.\",\n      \"evidence\": \"siRNA knockdown of MMP1/ADAMTS1, EGFR inhibitors, EGF-like ligand release assays, osteoclast differentiation assays, in vivo bone metastasis models\",\n      \"pmids\": [\"19608765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MMP1 directly cleaves all three EGF-like ligands or acts via intermediate proteases\", \"Relative contribution of MMP1 vs ADAMTS1 to ligand shedding\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"MMP1 was identified as a required effector of shear-stress-induced endothelial sprouting, linking hemodynamic forces to angiogenesis through MMP1 upregulation.\",\n      \"evidence\": \"Microfluidic shear stress devices with siRNA knockdown of MMP1 and 3D sprouting assays\",\n      \"pmids\": [\"24843171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanotransduction pathway connecting shear stress to MMP1 transcription not identified\", \"Relevant MMP1 substrates in sprouting angiogenesis not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Post-transcriptional regulation of MMP1 was established by miR-203 (via NF-κB) and miR-526b (direct 3′UTR targeting), expanding the regulatory landscape beyond transcriptional control.\",\n      \"evidence\": \"miR-203 overexpression with NF-κB inhibition in RA fibroblasts; 3′UTR luciferase reporter mutagenesis for miR-526b\",\n      \"pmids\": [\"21279994\", \"26292968\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether miR-203 directly targets MMP1 3′UTR or acts indirectly via NF-κB pathway modulation\", \"In vivo relevance of miR-526b regulation not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of LAMA5 as an MMP1 substrate whose proteolytic fragments promote angiogenesis via integrin αvβ3 defined a novel extracellular signaling axis connecting MMP1-mediated ECM cleavage to vascular growth.\",\n      \"evidence\": \"Mass spectrometry substrate identification, integrin αvβ3 blocking antibody, MMP1 siRNA with xenograft tumor volume measurement\",\n      \"pmids\": [\"27324842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific LAMA5 cleavage sites not mapped\", \"Whether other laminin subunits are also MMP1 substrates\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"EV-packaged MMP1 mRNA from metastatic ovarian cancer cells was shown to induce mesothelial cell apoptosis, revealing a non-canonical mechanism of MMP1 delivery for peritoneal metastasis.\",\n      \"evidence\": \"EV transcriptome analysis, qRT-PCR of MMP1 mRNA in EVs, in vitro apoptosis assays, in vivo peritoneal dissemination model\",\n      \"pmids\": [\"28262727\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether EV-delivered MMP1 mRNA is translated into functional protein in recipient cells not directly shown\", \"Mechanism of selective MMP1 mRNA packaging into EVs unknown\", \"Single-lab finding not independently replicated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The CIC–ETV4–MMP1 axis was established in hepatocellular carcinoma: CIC suppresses ETV4, which directly transactivates MMP1, and MMP1 knockdown fully rescues CIC-deficiency phenotypes, placing MMP1 as the terminal effector of this invasion-driving cascade.\",\n      \"evidence\": \"Epistatic knockdown/overexpression of CIC, ETV4, and MMP1 with luciferase reporter assays and in vivo xenograft\",\n      \"pmids\": [\"29251790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CIC–ETV4–MMP1 axis operates in non-HCC cancers\", \"Direct ETV4 binding sites on MMP1 promoter not mapped by ChIP in this study\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"MMP1 was shown to induce premature senescence in pulmonary fibroblasts through PAR-1 and oxidative stress, and senescent fibroblasts reciprocally promoted tumor growth, establishing MMP1 as a remodeler of the tumor microenvironment beyond direct ECM degradation.\",\n      \"evidence\": \"MMP1 overexpression/knockdown, co-culture senescence assays, PAR-1 inhibition, oxidative stress measurement, in vivo mouse models\",\n      \"pmids\": [\"33684534\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific PAR-1 downstream signaling events leading to senescence not fully mapped\", \"Whether this senescence-inducing function operates in non-pulmonary tissue stroma\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A positive feedback loop (MMP1/PAR1/ERK/ETV4/MMP1) was identified in tumor-associated macrophage–colon cancer cell communication, where TAM-derived MMP1 activates PAR1 to drive cell cycle progression and ETV4 feeds back to sustain MMP1 transcription.\",\n      \"evidence\": \"Exogenous MMP1, PAR-1/MEK inhibitors, ChIP for ETV4 at MMP1 promoter, cell cycle analysis, in vivo experiments\",\n      \"pmids\": [\"34753916\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative contribution of the feedback loop vs unidirectional signaling not measured\", \"Single-lab study; independent replication needed\", \"Whether loop operates in non-colon cancer contexts\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"NAT10-mediated ac4C modification of MMP1 mRNA was identified as a post-transcriptional stabilization mechanism promoting OSCC invasion, revealing epitranscriptomic control of MMP1 expression.\",\n      \"evidence\": \"NAT10 knockdown, acRIP-seq, MMP1 mRNA stability assays, MMP1 overexpression rescue, xenograft experiments\",\n      \"pmids\": [\"37705232\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific ac4C sites on MMP1 mRNA not mapped at nucleotide resolution\", \"Whether other epitranscriptomic modifications regulate MMP1 mRNA\", \"Single-lab finding not independently confirmed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the paracrine factor mediating UV-keratinocyte-to-fibroblast MMP1 induction, the structural mechanism by which the hemopexin domain cooperates with the catalytic domain to unwind triple-helical collagen, and whether the EV-mediated MMP1 mRNA transfer mechanism generalizes across cancer types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length MMP1 structure with collagen substrate\", \"Paracrine UV mediator unidentified\", \"EV-mediated MMP1 mRNA transfer lacks independent replication\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3, 4, 5, 6, 7, 8, 9, 15, 26]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [2, 6, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 6, 7, 9, 15, 26]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [6, 26]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [38]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [6, 8, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 15, 34, 35]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 15, 29, 34]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PAR1\",\n      \"TIMP1\",\n      \"TIMP2\",\n      \"MMP7\",\n      \"ETV4\",\n      \"LAMA5\",\n      \"IGFBP3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}